Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

John R. Raymond MD
President, CEO, Professor
Department of President

OFFICE ADDRESS:
Medical Education Building
8701 Watertown Plank Rd
Milwaukee, WI 53226

CITIZENSHIP:  USA

EDUCATION:
9/1974 - 6/1978 B.S., The Ohio State University, Columbus, Ohio
7/1978 - 6/1982 M.D., The Ohio State University, Columbus, Ohio

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
7/1982 - 6/1983 Internship in Medicine, Duke University Medical Center, Durham, NC
7/1983 - 6/1985 Residency in Medicine, Duke University Medical Center, Durham, NC
7/1985 - 6/1986 Fellowship in Nephrology, Duke University Medical Center, Durham, NC
7/1986 - 6/1987 Chief Medical Residency, Durham VA Medical Center, Durham, NC
7/1987 - 6/1988 Fellowship in Nephrology, Duke University Medical Center, Durham, NC

FACULTY APPOINTMENTS:
7/1986 - 6/1987 Associate in Medicine, Duke University Medical Center, Durham, NC
7/1989 - 6/1989 Associate in Medicine, Duke University Medical Center, Durham, NC
7/1989 - 6/1994 Assistant Professor of Medicine, Duke University Medical Center, Durham, NC
7/1994 - 6/1996 Associate Professor of Medicine, Duke University Medical Center, Durham, NC
8/1995 Tenure granted, Duke University Medical Center, Durham, NC
7/1996 - 6/2010 Dialysis Clinics Incorporated, Professor of Medicine with tenure, Medical University of South Carolina, Charleston, SC
7/19/2010 - Present Graduate Faculty, MUSC, Charleston, SC
7/2010 - Present Adjunct Professor of Medicine, MUSC, Charleston, SC

ADMINISTRATIVE APPOINTMENTS:
8/1991 - 11/2006 Associate Provost for Research, Medical University of South Carolina, Charleston, SC
7/1998 - 6/2002 Associate Chief of Staff for Research, Ralph H. Johnson VA Medical Ctr., Charleston, SC
7/2002 - 12/2002 Interim Vice President for Academic Affairs, and Provost, MUSC, Charleston, SC
1/2003 - 6/2010 Vice President for Academic Affairs, and Provost, MUSC, Charleston, SC
7/2010 - Present President and CEO, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
7/1996 - 6/2010 Executive Committee, Nephrology Fellowship Program, MUSC, Charleston, SC

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
7/1991 - 6/1993 Director of Dialysis, Durham VA Medical Center, Durham, NC
7/1991 - 6/1993 Renal Clinic Director, Durham VA Medical Center, Durham, NC
7/1991 - 6/1996 Chief, Nephrology Section, Durham VA Medical Center, Durham, NC
7/1992 - 6/1996 Coordinator, Hypertension Detection and Screening Program, Durham VA Medical Center, Durham, NC

HOSPITAL STAFF PRIVILEGES:
7/1986 - 6/1987 Duke University Medical Center, Durham, NC
7/1986 - 6/1987 Durham VA Medical Center, Durham, NC
7/1988 - 6/1996 Duke University Medical Center, Durham, NC
7/1988 - 6/1996 Durham VA Medical Center, Durham, NC
7/1996 - 6/2010 Ralph H. Johnson VA Medical Ctr., Charleston, SC
7/1996 - 6/2010 Medical University Hospital Authority, Medical University of South Carolina, Charleston, SC
7/1996 - 6/2003 Charleston Memorial Hospital and Specialty Hospital, Charleston, SC
7/1996 - 6/2010 Medical University Hospital Authority, Medical University of South Carolina, Charleston, SC
7/1998 - 6/2004 Hampton Regional Medical Center, Hampton, SC
7/2003 - 6/2010 Kindred Hospital of Charleston, Charleston, SC
11/2010 - Present Clement J. Zablocki VA Med. Center, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Internal Medicine:Medicine
9/10/1986
None
ABI: Nephrology
11/1/1988
None
American Heart Assn:Cardiopulmonary Resuscitation
10/19/2009
11/1/2011
 
Licensure
Number Issue DateExpiration
Ohio License(INACTIVE)
479660
7/1/1982
12/31/1982
North Carolina Training License(INACTIVE)
7/1/1982
6/30/1986
North Carolina Permanent License
30459
7/1/1986
None
South Carolina Permanent License
18867
7/1/1996
None
 
AWARDS AND HONORS:
1975 - Present Phi Kappa Phi Honor Society, Ohio State University
1982 Individual Service Award, Ohio Commission on Aging
1984 - 1985 Haskell Schiff Housestaff Award(most outstanding house officer), Duke University Medical Center, Department of Medicine
1987 Finalist, Golden Apple Award, Duke University School of Medicine
1987 Alpha Omega Alpha Honor Society Duke University School of Medicine
1991 Henry Christian Award for Excellence in Research, American Federation for Clinical Research
1994 Finalist, Eugene Stead Teaching Award from Medicine Housestaff, Duke University Medical Center, Department of Medicine
1995 Henry Christian Award for Excellence in Research, American Federation for Medical Research
1996 DCI Endowed Professorship, Medical University of South Carolina
1996 - 2000 Who's Who in Medicine/Healthcare, Marquis Who's Who
1996 - 2000 Who's Who in the World, Marquis Who's Who
1998 - 2002 Who's Who in Science/Engineering, Marquis Who's Who
2000 Strathmore's Who's Who, Millenium Edition
2000 Marquis Who's Who, Millenium Edition
2000 International Who's Who, International Who's Who of Professionals
2001 Federal Employee of the Year, Federal Executive Association, Greater Charleston Area
2001 - 2002 Distinguished Alumnus, Archbishop Hoban High School, Akron, Ohio
2001 - 2002 Outstanding Professional, America's Registry of Outstanding Professionals
2001 - 2002 Who's Who, National Registry of Who's Who
2001 - 2002 Strathmore's Who's Who, Strathmore's Who's Who
2002 Who's Who in America, Marquis Who's Who in America
2004 Diversity Advocate of the Year, South Carolina Commission on Higher Education
2005 Henry Middleton Award for Research Excellence, Department of Veterans Affairs, VISN7
2007 Presidential Service Citation for Service, South Carolina Dental Association
2009 Best Doctors™ citation Best Doctors in America-Nephrology
2009 Marcy Speer Outstanding Reviewer Award, NIH Center for Scientific Review
2010 Citation for Service, College of Nursing, Medical University of South Carolina
2010 Citation for Service, University of South Carolina-Columbia School of Medicine
2010 Citation for Service, Health Sciences South Carolina
2010 Doctor of Medical Science Honoris Causa, Medical University of South Carolina (Honorary degree)
2010 John R. Raymond, M.D. Scholarship created, Medical University of South Carolina
2010 Annual John R. Raymond Mentorship Award created, Medical University of South Carolina
2010 Citation for Service, Office of Student Diversity, Medical University of South Carolina
2010 Best Doctors™ citation Best Doctors in America-Nephrology
2010 Honorary Nurse designation, College of Nursing, Medical University of South Carolina

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1975 - Present Phi Kappa Phi (Member)
1981 - Present American Medical Association (Member)
1986 - Present American College of Physicians (Member)
1987 - Present Alpha Omega Alpha (Member)
1988 - Present American Society of Nephrology Member
1989 - Present American Federation for Medical Research (Member)
1990 - Present American Heart Association (Member)
1990 - Present National Kidney Foundation (Member)
1991 - Present American Society of Nephrology (Session Chair)
1994 - 2000 New York Academy of Sciences (Member)
1995 - 1998 Annals of Internal Medicine (Readership Advisory Group)
1995 - Present American Society for Clinical Investigation (Member)
1995 - 2004 Molecular Medicine Society (Member)
1996 - Present Hypertension Council of the American Heart Association (Member)
1996 - 2010 Southern Society for Clinical Investigation (Member)
1996 - 2010 Southern Salt, Water and Kidney Club (Member)
1996 - Present Hypertension Council of the American Heart Association (Fellow)
1997 - Present American Society of Nephrology (Session Chair)
1997 - 2004 Molecular Medicine Society (Fellow)
1998 - Present Association of American Physicians (Member)
1999 - Present American Society of Pharmacology Experimental Therapeutics (Member)
2003 - 2008 American Society for Biochemistry Molecular Biology (Member)
2004 - Present American Society of Nephrology (Session Chair)
2007 - Present American Society of Nephrology (Session Chair)
2009 - Present American Heart Association (Fellow)
2009 - Present American College of Physicians (Fellow)
2009 - Present American Society of Nephrology (Fellow)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
7/2001 - 6/2010 American Journal of Physiology Renal Physiology
7/2003 - 6/2008 Journal of Biological Chemistry
7/2004 - Present ASSAY and Drug Development Technology
Journal Review
American Journal of PharmacoGenomics
American Journal of Physiology: Cell
American Journal of Physiology: Endocrine
American Journal of Physiology: Integrative
Am. J. Resp. Cell Mol. Biol.
Annals of Internal Medicine
Biochem Biophys Acta
Biochemical Pharmacology
Biochemistry
Biological Psychiatry
Biophysical Journal
Brain Research
British Journal of Pharmacology
Cellular and Molecular Cardiology
Circulation
Circulation Research
Current Medicinal Chemistry
Diabetes
FASEB Journal
FEBS Letters
Geriatrics
Tissue and Cell
International Journal of Neuropsychopharmacology
Journal of the Am. Society of Nephrology
Journal of Applied Physiology
Journal of Cell Science
Journal of Clinical Investigation
Journal of Immunology
Journal of Investigative Dermatology
Journal of Molecular and Cellular Cardiology
Journal of Neurochemistry
Journal of Neuroimmunology
Journal of Neuroscience
Journal of Pharmacology & Experimental Therapeutics
Journal of Vascular Research
Kidney International
Life Sciences
Molecular Membrane Biology
Molecular Pharmacology
Nature Molecule Pages
Neuropsychoimmunology
Neuropsychoimmunology
New England Journal of Medicine
New England Journal of Medicine
North Carolina Medical Journal
Pharmacogenomics
Physiological Genomics
Physiological Journal
Proc. Natl. Acad. Sci. U.S.A.
American Journal of Pathology
American Journal of Kidney Diseases
American Heart Journal
Hypertension

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1999 - 2002 Charleston Research Institute, Secretary-Treasurer, Board of Directors, Directors
2001 - 2010 Foundation for Research Development, MUSC, Vice-Chair, Board of Directors
2001 - 2009 Hollings Marine Laboratory,South Carolina, Board of Directors (Chair 2001-2006)
2001 - 2010 University Medical Associates (Affiliated Physicians' Practice of MUSC), Executive Committee, Board of Directors
2002 - 2006 Charleston Research Institute, Member, Board of Directors
2002 - 2010 SC State EPSCOR/IDEA Committee Executive Board(Chair, South Carolina University Research and Education Foundation, Member, Board of Trustees, Chair (2005-2006)
2002 - 2010 Lowcountry Graduate Center, Board of Directors, Chair, Executive Committee
2003 - 2010 Governor's School for Science and Mathematics, State of South Carolina, Member, Board of Trustees
2003 - 2010 South Carolina Bio, State of South Carolina, Member, Board of Directors
2003 - 2010 University Center at Greenville, Board of Directors, Executive Committee
2004 - 2010 Health Sciences South Carolina, Member, Scientific Committee (VPs of six partners)
2006 - 2007 Charleston Regional Development Alliance, Member, Board of Directors
2007 - 2010 South Carolina BioEngineering Alliance, Member, Board of Directors
2007 - 2010 South Carolina College of Pharmacy, Member, Board of Trustees
2010 - Present Greater Milwaukee Committee, Member
2010 - Present National Kidney Foundation of Wisconsin, Member, Board of Directors
2010 - Present American Heart Association of Wisconsin, Member, Board of Directors
2010 - Present Consortium on Community and Public Health, Member, Executive Committee
2010 - Present Milwaukee Health Care Partnership, Member, Board of Directors
2010 - Present Milwaukee Regional Medical Center, Member, Board of Directors
2011 - Present Milwaukee County Research Park Member, Board of Directors
2011 - Present Milwaukee Academy of Science, Member, Board of Directors, http://milwaukeeacademyofscience.org/
2011 - Present Center for International Health Milwaukee, Member, Board of Directors, (http://centerforinternationalhealth.org/)
2011 United Way of Greater Milwaukee, Member, Campaign Cabinet Co-Chair, Healthcare
2011 American Heart Association of Wisconsin, Chair, Heart Walk

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1989 Medical Research Council of Canada, Ad hoc grant referee
1990 Department of Veterans Affairs Gastroenterology Study Section, Ad hoc grant referee
1991 Department of Veterans Affairs, Basic Sciences Study Section, Ad hoc grant referee
1991 - 2001 Department of Veterans Affairs Nephrology Study Section, Ad hoc grant referee
1992 - 1995 National Kidney Foundation Young Investigator Grants, Study section member
1992 National Institutes of Health Experimental Cardiovascular Sciences Study Section, NHLBI Ad hoc grant referee
1992 - 2001 Wellcome Trust Individual Investigator Awards, Ad hoc grant referee
1993 - 2003 Jewish Foundation of Louisville Biomedical Research Awards, Ad hoc grant referee
1993 - 1996 National Institutes of Health Neurological Sciences 2 Study Section, Ad hoc grant referee
1994 - 1996 National Science Foundation Neural & Glial Mechanisms, Ad hoc grant referee
1996 - 1997 National Institutes of Health Neurological Sciences 1 Study Section, NINDS Ad hoc grant referee
1997 National Institutes of Health Mt. Sinai Pharmacology PPG, NIA Special Emphasis Panel
1997 National Institutes of Health New York University Neuroscience PPG, NIA Special Emphasis Panel
1997 - 1998 National Institutes of Health Neurological Sciences 1 Study Section, NINDS Study section member (disbanded due to reorganization)
1997 National Institutes of Health Signaling Laboratory, NIMH Intramural Review Panel
1997 National Science Foundation Signal Transduction and Molecular Biochemistry, Ad hoc grant referee
1998 - 2002 American Heart Association, Cardio-Renal Study Section member; co-Chair, 2000 & 2001
1998 - 1999 National Institutes of Health Molecular Developmental Cellular Neurosciences 5 Study Section (MDCN-5), NINDS Ad hoc grant referee
1998 National Institutes of Health Yale Physiology PPG, NIDDK Special Emphasis Panel
1998 National Institutes of Health Vanderbilt Nephrology PPG, NIDDK Special Emphasis Panel
1998 National Institutes of Health General Medicine B Study Section, NIDDK Ad hoc grant referee
1999 National Institutes of Health Physiological Sciences Study Section, Ad hoc grant referee
1999 - 2004 National Institutes of Health MDCN-5, NINDS Study section member
1999 Department of Veterans Affairs Central Office, R & D Service, Member, Research Career, Scientist Program Task Force
1999 Department of Veterans Affairs Pulmonary, Renal and Gastrointestinal, Adjudicator, Merit Review Appeal
1999 Department of Veterans Affairs Pulmonary, Renal and Gastrointestinal, Chair, Research Enhancement Area Program, Special Emphasis Panel
2000 - 2001 Department of Veterans Affairs Office of Research Compliance and Assurance, Chair, Animal Welfare Task Force
2000 Department of Veterans Affairs Central Office, R & D Service, Chair, San Diego VA/JDFI Diabetes Research Center Site Visit
2000 National Institutes of Health, NHLBI Special Emphasis Panel
2000 - 2001 Department of Veterans Affairs Office of Research Compliance and Assurance Multi-Assessment Program, Member, Task Force
2000 Department of Veterans Affairs Central Office, R & D Service, Chair, Iowa City VA/JDFI Diabetes Research Center Site Visit
2000 Department of Veterans Affairs Central Office, R & D Service, Chair, Nashville VA/JDFI Diabetes Research Center Site Visit
2000 Department of Veterans Affairs Central Office, R & D Service, Member, Middleton Award Selection Committee
2001 National Institutes of Health Emory University PPG site visit, NIDDK Special Emphasis Panel
2001 Department of Veterans Affairs Central Office, R & D Service, Merit Review Advisory Council
2001 National Institutes of Health, NINDS Special Emphasis Panel
2001 National Institutes of Health NIDDK, NIDDK Special Emphasis Panel, Centers of Excellence in Pediatric Nephrology
2001 National Institutes of Health, NIGMS Special Emphasis Panel
2001 Medical Research Council, United Kingdom, Ad hoc grant referee
2002 National Institutes of Health NIDDK, NIDDK Special Emphasis Panel, Loan Repayment Program
2003 National Institutes of Health NIDDK, NIDDK Special Emphasis Panel, Loan Repayment Program
2003 Department of Veterans Affairs Central Office, R & D Service, Research Enhancement Award, Program Advisory Council
2003 National Institutes of Health, Center for Scientific Review, ZRG1 MDCN-1 Special Emphasis Panel, Functional and Cognitive Neuroscience 1 Study Section (IFCN1)
2003 National Institutes of Health, Center for Scientific Review, ZRG1 UROL Special Emphasis Panel, Urology Study Section (NIDDK)
2003 National Institutes of Health, Center for Scientific Review, ZRG1 MDCN-1 Special Emphasis Panel (SYN)
2003 National Institutes of Health NIDDK, NIDDK Special Emphasis Panel, Loan Repayment Program
2003 National Institutes of Health Center for Scientific Review, ZRG1 MDCN-5 Special Emphasis Panel
2003 - 2007 Department of Veterans Affairs Central Office, R & D Service, Renal Study Section member
2004 - 2007 National Institutes of Health NINDS, MNPS Study section member, Chair(2005-2007)
2004 National Institutes of Health Center for Scientific Review/NIDDK, ZRG1 RUSD (04) Special Emphasis panel, Calcitropic Hormones & Renal Transport
2004 National Institutes of Health Center for Scientific Review/NIDDK, Co-Chair ZRG4 UROL Special Emphasis Panel, Roadmap T-90 Grants
2004 National Institutes of Health NIDDK, ZDK GRB-3 Special Emphasis Panel, Loan Repayment Program
2004 National Institutes of Health NIDDK, ZDK GRB-3 Special Emphasis Panel, Loan Repayment Program
2004 National Institutes of Health NIDDK - Emory and Colorado PPGs, ZDK1 GRB-1 (02) Special Emphasis Panel, PPG Review
2004 National Institutes of Health NIDDK, Chair, ZDK GRB-R (J1) Special, Emphasis Panel, Training grants
2004 National Institutes of Health Center for Scientific Review/NIDDK, ZRG3 UROL Special Emphasis Panel; Emphasis Panel, Novel Technologies
2005 National Institutes of Health NIDDK, ZDK GRB-C (M1) Special Emphasis Panel, Neph. Ancillary Clinical Trials
2005 National Institutes of Health NIDDK, Chair, ZDK GRB-R (02) Special Emphasis Panel, Nephrology K awards
2005 National Institutes of Health NIDDK, ZRG1 ZRG1 F10-H 20L Special Emphasis Panel, F31 and F32 proposals
2005 National Institutes of Health NINDS, ZNS1 SRB-G (01) Special Emphasis Panel, High Throughput Screening
2005 National Institutes of Health NIDDK, ZRG1 RUS-D (02) (M) Special Emphasis Panel, Collaborative R01 proposals
2005 National Institutes of Health NIDDK, ZDK GRB-4 (01) Angiogenesis in Diabetes, Special Emphasis Panel
2006 National Institutes of Health NINDS, ZNS1 SRB-G (01) Special Emphasis Panel, High Throughput Screening - Roadmap
2006 National Institutes of Health NIDDK, Chair, ZDK1 GRB-R (02) Special Emphasis Panel, Nephrology Ancillary Clinical Trials
2006 National Institutes of Health NIDDK, ZRG1 F10-H 21L-2 Special Emphasis Panel, F31 and F32 proposals
2006 National Institutes of Health NIDDK, ZRG1 ZRG1 F10-H 21L-1, Special Emphasis Panel, F31 and F32 proposals
2006 National Institutes of Health NIDDK, ZDK GRB-5 Special Emphasis Panel, Loan Repayment Program
2007 National Institutes of Health NIMH, ZMH1 ERB-Y (06) S, Special Emphasis Panel, Molecular Libraries Screening Assays
2007 National Institutes of Health NIMH, Chair, ZMH1 ERB-Y (07) S, Special Emphasis Panel, Molecular Libraries Screening Assays
2007 National Institutes of Health NIDDK, ZDK GRB-6 Special Emphasis Panel, Loan Repayment Program
2007 National Institutes of Health NIDDK, ZRG1 F10-H 22 Special Emphasis Panel, F31 and F32 proposals
2007 National Institutes of Health NIDDK, ZDK GRB- W (M1) Special Emphasis Panel, Research Centers of Excellence in Pediatric Nephrology
2007 National Institutes of Health NCRR, 2007/10 ZRR1 CR-1 (01) CTSA Special Emphasis Panel 2007 (#1)
2007 National Institutes of Health NIDDK, ZDK GRB-9 M2 1 Special Emphasis Panel, Clinical Research Studies
2/2008 National Institutes of Health NIDDK, PBKD Study Section, ad hoc reviewer
3/2008 National Institutes of Health NIDDK, ZRG1 F10-H 20L Special Emphasis Panel, F31 and F32 proposals
6/2008 National Institutes of Health NIDDK, PBKD Study Section, ad hoc reviewer
10/2008 National Institutes of Health NIDDK, Chair, ZRG1 F10-H 20 Special Emphasis Panel, F31 and F32 proposals
2008 National Institutes of Health NIDDK, ZDK GRB-7 Special Emphasis Panel, Loan Repayment Program
2008 National Institutes of Health NIDDK, Kidney, Urologic and Hematologic Diseases Sub-Committee D, ad hoc
2008 Institute of Medicine Workshop on Safety Biomarkers, Member
2008 National Institutes of Health NIDDK, Prospective Study of Chronic Kidney Disease (CRIC) Special Emphasis Panel
2008 National Institutes of Health NIDDK/NHLBI, Chair, ZDK GRB-6 (J2) 1; Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies Special Emphasis Panel
2008 National Institutes of Health NIDDK, RUS-C 02M Special Emphasis Panel, CMBK Member Conflicts
2008 National Institutes of Health NIDDK, ZRG1 F10-H 23 Special Emphasis Panel, F31 and F32 proposals
2009 - Present National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (M1) L KUH F30/32 award Study Section
2009 National Institutes of Health Center for Scientific Review, Chair, ZRG1 EMNR-H (52) R ARRA AREA Award Review SEP
2009 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (M4) 1 Special Emphasis Panel, CMBK Member, Conflicts Study Section
2009 National Institutes of Health NIDDK, ZDK GRB-N (M1) Special Emphasis Panel, Loan Repayment Program
2009 National Institutes of Health NIDDK, Chair, ZRG1 DKUS-B02M DKUS (PBKD and UKGD) Member, Conflicts Special Emphasis Panel
2009 National Institutes of Health Special Center for Scientific Review, ZRG1 MDCN-A (58) R ARRA Special Emphasis Panel for NIH Challenge Grants - Stage 1
2009 National Institutes of Health Center for Scientific Review, ZRG1 BST-J (51) S Roadmap HTS Assay Development
2009 National Institutes of Health NIDDK, ZDK1 GRB-S (O2) 2 Emory Physiology, PPG Special Emphasis Panel
2009 National Institutes of Health Center for Scientific Review, ZRG1 DKUS A 58 (R) ARRA Special Emphasis Panel for NIH Challenge
2009 National Institutes of Health Center for Scientific Review, ZRG1 BDAL A 58 (E) ARRA Special Emphasis Panel for NIH Challenge Grants - Stage 2
2009 - 2013 National Institutes of Health NIDDK, Member, PBKD Study Section Chair (2011-2013)
2009 National Institutes of Health NIDDK, ZDK1 GRB-S (O4) 2 NIDDK-P50 PKD ARRA Supplement review
2009 National Institutes of Health Center for Scientific Review, ZRG1 BST-J (50) R Roadmap HTS Assay for MLPCN
2009 National Institutes of Health NIDDK, ZDK1 GRB-G (J2) 1 HUKD SEP Training and Mentored Awards
2009 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (J1) 1, KUH Fellowship Review Committee
2009 National Institutes of Health Center for Scientific Review, ZRG1 BST-J (51) R Roadmap HTS Assay Development
2/23/2010 U.S. House of Representatives Committee on Science and Technology. Subcommittee on Research and Science Education. Invited testimony
2010 National Institutes of Health Chair NIDDK, ZDK1 GRB-G (M1) 1 KUH Fellowship Review Committee
2010 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (M2) 1, K-Award SEP for conflicts
2010 - 2013 National Institutes of Health Center for Scientific Review, Inaugural Cohort, College of Scientific Reviewers
2010 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (O1) L, KUH-Fellowship Review
2010 National Institutes of Health NIDDK, ZDK1 GRB-9 (O1), Cellular Signaling and Kidney Function
2010 National Institutes of Health NIDDK, ZDK1 GRB-N (M3), Loan Repayment Program
2010 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (J1), KUH-Fellowship Review
2010 National Institutes of Health Center for Scientific Review, Review Committee, Marcy Speer Outstanding Reviewer Award
2010 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (J2) 1, KUH-Fellowship Review (conflicts SEP)
2010 National Institutes of Health Center for Scientific Review, ZRG1 BST-J (50) R Roadmap HTS Assay for MLPC
2010 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (O2) 1, KUH-Fellowship Review (conflicts)
2011 National Institutes of Health NIDDK, Chair, ZDK1 GRB-G (M1) 1, KUH-Fellowship Review
2011 National Institutes of Health NIDDK, ZRR1 CR-3 (01), CTSA Review
2011 - 2014 American Society of Nephrology, Finance Committee
2011 - 2013 National Institutes of Health Center for Scientific Review, Chair, PBKD Pathobiology of Kidney Disease Study Section
2011 National Institutes of Health NIDDK, ZDK1 GRB-N (M6) Loan Repayment Program

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
G Protein-Regulation of NHE Activity
Source:
National Institutes of Health R01 DK52448-11
Role:
Principal Investigator (2008-2013)
Dates:
1996 - 2013
Direct Funds:
$1,175,000
 
Title:
G Protein-Regulation of NHE Activity (ARRA supplement)
Source:
National Institutes of Health R01 DK52448-11
Role:
Principal Investigator
Dates:
2009 - 2011
Direct Funds:
$100,000
 
Title:
Roles for Cbl and ESCRT Proteins in 5-HT Receptor Function
Source:
Veterans Affairs Merit Award
Role:
Principal Investigator
Dates:
2009 - 2013
Direct Funds:
$623,000 (Transfer to Zablocki VA Medical Center has been requested)
 
Prior
Peer Review
Title:
Regulation of Phosphate Transport in Transfected Cells
Source:
American Heart Association (National) Grant-In-Aid 900767
Role:
Principal Investigator
Dates:
1990 - 1993
Direct Funds:
$105,000
 
Title:
Cell Biology and Biochemistry of the Human 5-HT1A Receptor
Source:
Veterans Administration Merit Award
Role:
Principal Investigator
Dates:
1990 - 1993
Direct Funds:
$123,000
 
Title:
Electron Paramagnetic Spin Resonance Facility
Source:
Shared Equipment Grant NIH S10 RR13656
Role:
Principal Investigator
Dates:
1991
Direct Funds:
$306,000
 
Title:
Regulation of Signaling of the Human 5-HT1A Receptor
Source:
National Institutes of Health R01 NS30927
Role:
Principal Investigator
Dates:
1992 - 1995
Direct Funds:
$351,000
 
Title:
Heterologous Expression, Purification and Reconstitution of the 5-HT1A Receptor
Source:
Veterans Administration Merit Award
Role:
Principal Investigator
Dates:
1993 - 1998
Direct Funds:
$367,000
 
Title:
Characterization of Novel Derivatives of (S) UH-301 for the Study of the 5-HT1A Receptor
Source:
National Institutes of Health SBIR Grant
Role:
Co-investigator (subcontract)
PI:
Yigong Gao, Research Biochemicals International
Dates:
1994 - 1995
Direct Funds:
$12,000
 
Title:
Determinants of Polarity in Type IIIb Membrane Proteins
Source:
American Heart Association (National) Grant-In-Aid 940507
Role:
Principal Investigator
Dates:
1994 - 1997
Direct Funds:
$120,000
 
Title:
Cytosensor® Microphysiometer
Source:
Department of Veterans Affairs Equipment Grants Program
Role:
Ombudsman
Dates:
1995
Direct Funds:
$50,000
 
Title:
Cytosensor® Microphysiometer Academic Grant
Source:
Molecular Devices Corporation
Role:
Ombudsman
Dates:
1995
Direct Funds:
$47,500
 
Title:
Gi Regulation of NHE Activity in Renal and Fibroblast Cells
Source:
National Institutes of Health R01 DK52448
Role:
Principal Investigator
Dates:
1996 - 2001
Direct Funds:
$650,000
 
Title:
Role of Aldosterone in Renal Glomerular Cell Growth and Matrix Production
Source:
Mentored NIH K01 HL96012
Role:
Sponsor
PI:
Eddie L. Greene
Dates:
1997 - 2002
Direct Funds:
$450,000
 
Title:
Charleston Inflammatory Mediators of Glomerular Diseases REAP Award
Source:
Veterans Affairs Research Enhancement Award Program
Role:
Program Director (Relinquished to new PI Dr.Gary Gilkeson upon move to MCW 7/1/2010
Dates:
1998 - 2010
Direct Funds:
$3,100,000
 
Title:
Differential Signaling of Serotonin Receptors
Source:
Veterans Administration Merit Award
Role:
Principal Invest
Dates:
1998 - 2003
Direct Funds:
$533,000
 
Title:
MUSC Multidisciplinary Training Grant in Glomerular Function and Disease
Source:
Training Grant in Glomerular Function and Disease NIH T32 DK07752-11
Role:
Program Director (Relinquished to new PI Dr.P.Darwin Bell upon move to MCW 7/1/2010)
Dates:
1998 - 2014
Direct Funds:
$1,880,000
 
Title:
Pathways of Hypertonic Activation of Sodium-Proton Exchange
Source:
Mentored Department of Veterans Affairs Merit Award (MREP)
Role:
Sponsor
PI:
Maria N. Garnovskaya PhD
Dates:
1998 - 2001
Direct Funds:
$300,000
 
Title:
Live Cell Fluorescence Microscopy Facility
Source:
Department of Veterans Affairs Equipment Grants Program
Role:
Principal Investigator
Dates:
1998
Direct Funds:
$209,000
 
Title:
MUSC Integrated Cellular Fluorescence Facility
Source:
Shared Equipment Grant NIH S10 RR13005
Role:
Principal Investigator (effort N/A)
Dates:
1998
Direct Funds:
$281,000
 
Title:
Minority Faculty Development Award
Source:
Mentored Robert Wood Johnson Minority Faculty Development Award
Role:
Sponsor
PI:
Eddie L. Greene
Dates:
1998 - 2002
Direct Funds:
$325,000
 
Title:
NAD(P)H Oxidase & Mesangial Cell Proliferation and Fibrosis
Source:
National Institutes of Health R01 DK54720-04
Role:
Principal Investigator
Dates:
2000 - 2005
Direct Funds:
$700,000
 
Title:
Bradykinin Regulation of Inner Medullary Collecting Duct Proton Flux
Source:
Mentored NIH K01 DK02694-02
Role:
Sponsor
PI:
Yurii V. Mukhin PhD
Dates:
2000 - 2003
Direct Funds:
$210,000
 
Title:
Cellular Actions of Indoxyl Sulfate - a Uremic Toxin
Source:
Mentored NIH K25 DK59950-05
Role:
Sponsor
PI:
Andrew Gelasco PhD
Dates:
2001 - 2007
Direct Funds:
$675,000
 
Title:
Down-regulation of EGF Receptors by GPCR Activation
Source:
National Institutes of Health R01 GM-63909-04
Role:
Principal Investigator
Dates:
2001 - 2007
Direct Funds:
$700,000
 
Title:
Homocysteinemia in Chronic Renal Failure- Cooperative Trial
Source:
CSP #453 Department of Veterans Affairs
Role:
Local Principal Investigator
Dates:
2001 - 2005
Direct Funds:
$250,000
 
Title:
Gi Regulation of NHE Activity in Renal and Fibroblast Cells
Source:
Supplement National Institutes of Health R01 DK52448-06
Role:
Principal Investigator
Dates:
2001 - 2002
Direct Funds:
$25,000
 
Title:
Research Security Enhancement Award
Source:
Veterans Affairs RFA
Role:
Program Director
Dates:
2002
Direct Funds:
$20,000
 
Title:
Angiotensin Receptor Interacting Proteins
Source:
Mentored K01 DK063252-02
Role:
Sponsor
PI:
Qing Yang MD
Dates:
2002 - 2006
Direct Funds:
$250,000
 
Title:
Human Subjects Research Enhancement Program at MUSC
Source:
National Institutes of Health 1 S07 RR018244
Role:
Principal Investigator
Dates:
2002 - 2004
Direct Funds:
$300,000
 
Title:
Sensory Neuroscience Facility Renovation
Source:
NIH/NCRR 1C06RR014516
Role:
Principal Investigator (as institutional official)
Dates:
2002 - 2003
Direct Funds:
$1,000,000
 
Title:
NHE-1 Interacting Proteins
Source:
Mentored Minority supplement to NIH R01 DK52448-07
Role:
Sponsor
PI:
Henry Ayiku MD
Dates:
2002 - 2005
Direct Funds:
$200,000
 
Title:
Proteomics of NHE-1 Activation
Source:
Mentored Minority supplement to NIH R01 DK52448-07
Role:
Sponsor
PI:
Sonya Coaxum PhD
Dates:
2003 - 2005
Direct Funds:
$115,000
 
Title:
Children's Research Institute Animal Facility
Source:
NIH/NCRR 1C06 RR015455-01A1
Role:
Principal Investigator (as institutional official)
Dates:
2003 - 2005
Direct Funds:
$2,000,000
 
Title:
Children's Research Institute Developmental Neurogenetics And Cardiovascular Biology Floors
Source:
NIH/NCRR 1C06 RR018823
Role:
Principal Investigator (as institutional official)
Dates:
2003 - 2005
Direct Funds:
$2,854,000
 
Title:
Role of Calmodulin in 5-HT Receptor Function
Source:
NIH R01 NS049515
Role:
Principal Investigator (Declined in lieu of VA Merit Award)
Dates:
2004 - 2009
Direct Funds:
$1,125,000
 
Title:
Novel 5-HT Receptor-interacting Proteins
Source:
Veterans Affairs Merit Award
Role:
Principal Investigator
Dates:
2004 - 2009
Direct Funds:
$715,000
 
Title:
MUSC Multidisciplinary Training Grant in Glomerular Function and Disease Minority Training Supplement for Keidre Corbett, M.D.
Source:
Training Grant in Glomerular Function and Disease NIH T32 DK07752-07S1
Role:
Program Director
Dates:
2005 - 2007
Direct Funds:
$125,000
 
Title:
Crosstalk Among Growth Factors, ADAMs and Integrins
Source:
Mentored NIH 1 K01 DK070054
Role:
Sponsor
PI:
Monika Gooz MD PhD
Dates:
2005 - 2010
Direct Funds:
$520,000
 
Title:
G Protein-Regulation of NHE Activity
Source:
National Institutes of Health R56 DK052448-10A1 (Shannon Award)
Role:
Principal Investigator
Dates:
2007 - 2008
Direct Funds:
$283,500
 
Title:
MUSC Multidisciplinary Training Grant in Glomerular Function and Disease Minority Training Supplement for Evelyn Lewis M.D.
Source:
Training Grant in Glomerular Function and Disease NIH T32 DK07752-09S1
Role:
Program Director
Dates:
2007 - 2009
Direct Funds:
$126,000
 
Title:
Role of c-Cbl in Trafficking and Signaling of EGF Receptors Induced by Various Growth Factors
Source:
American Heart Association Mid-Atlantic Affiliate 0725358U
Role:
Mentor
PI:
Alex Baldys PhD(Fellowship)
Dates:
2007 - 2010
Direct Funds:
$105,000
 
Title:
Implications in Glomerular Injury
Source:
Mentored NIH 1 K08 DK080944-01
Role:
Sponsor (relinquished to Dr.P.Darwin Bell upon move to MCW 7/1/2010-Dr. Raymond remains member of mentorship committee)
PI:
Juan Carlos Velez MD
Dates:
2008 - 2013
Direct Funds:
$646,920
 
Title:
Renal Biomarkers Center of Excellence
Source:
South Carolina Centers of Economic Development
Role:
Principal Investigator (Relinquished to Dr. John M. Arthur upon move to MCW 7/1/2010)
Dates:
2008 - 2013
Direct Funds:
$5,000,000
 
Title:
Role of Ceramide in Aging-related Diseases
Source:
Mentored VA Career Development-2 Award
Role:
Co-sponsor (relinquished upon move to MCW 7/1/2010-Dr. Raymond remains member of mentorship committee-Lina Obeid is primary sponsor)
PI:
Leah Siskind, PhD
Dates:
2008 - 2011
Direct Funds:
$400,000 ($35,000 first year)
 
Title:
Regulation of 5-HT1A Receptor by Calmodulin
Source:
Mentored NIH 1 K01 HL
Role:
Sponsor (relinquished to Dr.Louis Luttrell upon move to MCW 7/1/2010-Dr. Raymond remains member of mentorship committee)
PI:
Sonya Coaxum PhD
Dates:
2008 - 2013
Direct Funds:
$567,867
 
Title:
Discovery of Urine Biomarkers in Patients with Glomerular Disease
Source:
Mentored VA Career Development-2 Award
Role:
Sponsor (relinquished to Dr.John M.Arthur upon move to MCW 7/1/2010-Dr. Raymond remains member of mentorship committee)
PI:
Michael Janech PhD
Dates:
2008 - 2011
Direct Funds:
$350,000
 
Title:
Basic Science Building
Source:
NIH/NCRR 1C06 RR020609
Role:
Principal Investigator
Dates:
2010 - 2012
Direct Funds:
$6,616,774
 
Non-Peer Review
Title:
National Kidney Foundation Fellowship, Frank J. Albers MD
Dates:
1991 - 1993
Direct Funds:
$50,000
 
Title:
National Kidney Foundation Fellowship, John M. Arthur MD PhD
Dates:
1995 - 1996
Direct Funds:
$25,000
 
Title:
American Heart Association(SC Affiliate) Yurii Mukhin PhD
Dates:
1997 - 1999
Direct Funds:
$40,000
 
Title:
National Kidney Foundation Fellowship(SC Affiliate), John C. Andy MD
Dates:
1998 - 1999
Direct Funds:
$25,000
 
Title:
National Kidney Foundation Fellowship(National), John C. Andy MD
Dates:
1998 - 1999
Direct Funds:
$12,500
 
Title:
American Heart Association(SC Affiliate), Jasjit Grewal PhD
Dates:
1998 - 2000
Direct Funds:
$50,000
 
Title:
Department of Veterans Affairs Associate Investigator, Andrew Gelasco PhD
Dates:
2000 - 2001
Direct Funds:
$60,000
 
Title:
Department of Veterans Affairs Associate Investigator, David Lefler DO
Dates:
2000 - 2001
Direct Funds:
$50,000
 
Title:
American Heart Association Pre-doctoral fellowship, Justin Turner(MSTP student)
Dates:
2002 - 2004
Direct Funds:
$17,000
 
Title:
NIH Minority Supplement for post-doctoral fellowship, Henry Ayiku MD
Dates:
2003 - 2005
Direct Funds:
$100,000
 
Title:
NIH Minority Supplement for post-doctoral fellowship, Sonya Coaxum PhD
Dates:
2004 - 2006
Direct Funds:
$110,000
 
Title:
American Heart Association Mid-Atlantic Affiliate Post-doctoral fellowship, Aleksander Baldys PhD
Dates:
2005 - 2010
Direct Funds:
$120,000
 
Title:
NIH Minority Supplement for post-doctoral fellowship, Keidre Jenkins Corbett MD
Dates:
2005 - 2007
Direct Funds:
$105,000
 
Title:
Department of Veterans Affairs Associate Investigator, Juan Carlos Velez MD
Dates:
2005 - 2007
Direct Funds:
$120,000
 
Title:
NIH Minority Supplement for post-doctoral fellowship, Evelyn Lewis MD
Dates:
2005 - 2007
Direct Funds:
$62,000
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
1. Pathways of Signal Initiation and Termination through a Prototypical Gi-linked Receptor. Research Conference, University of Florida Division of Nephrology, Hypertension and Transplantation, Gainesville, Florida, 1994
2. Acquired and Genetic Diseases of G proteins and their Receptors. Clinical Conference, University of Florida Division of Nephrology, Hypertension and Transplantation, Gainesville, Florida , 1994
3. Promiscuous Signal Initiation and Termination through a Prototypical Gi-linked Receptor. University of Cincinnati Division of Pulmonary Medicine, Cincinnati, OH, 1994
4. Microphysiometry as a Tool to Study Receptors and Sodium-Proton Antiporters. Satellite Conference, FASEB Meeting, Atlanta, Georgia, 1994
5. Multiple Pathways of Signal Initiation and Termination through a Prototypical Gi-linked Receptor. Research Conference, University of Louisville Kidney Disease Program, 1994
6. Acquired and Genetic Diseases of G proteins and their Receptors. Clinical Conference, University of Louisville Kidney Disease Program, 1994
7. Microphysiometry, a New Tool for the Study of Signal Transduction. University of Florida Division of Nephrology, Hypertension and Transplantation, and Department of Pharmacology, Gainesville, Florida, 1995
8. Strategies to Slow the Progression of Diabetic Renal Disease. Medical Grand Rounds, Marshall University, Huntington, W.Va, 1995
9. Acquired and Hereditary Diseases of G Proteins and their Receptors. Medical Grand Rounds, Duke University Medical Center, 1995
10. Microphysiometry, a New Tool for the Study of Signal Transduction. The Society for Neuroscience Annual Meeting, San Diego, CA, 1995
11. Microphysiometry to Study Orphan Receptors and Signal Transduction. Pathways Satellite Symposium, Society for Neuroscience Annual Meeting, San Diego, CA, 1995
12. Strategies to Slow the Progression of Diabetic Renal Disease. Medical Grand Rounds, Duke University Medical Center, 1995
13. Chair, Signal Transduction Session. American Society of Nephrology Meeting, San Antonio, Texas, 1997
14. Signal Transduction Session (Session Chair) 2nd International Symposium on Microphysiometry and FLIPR Technology, Hilton Head, SC, 1998
15. The Study of Sodium-Proton Exchange using Microphysiometry. 2nd International Symposium on Microphysiometry and FLIPR Technology, Hilton Head, SC, 1998
16. Probing Cellular Metabolic Pathways with Noninvasive Methods. 3rd International Symposium on Microphysiometry and FLIPR Technology, Monterey, California, 1999
17. Molecular and Clinical Aspects of Diabetes Insipidus. Clinical Conference, University of Louisville Kidney Disease Program, 1999
18. Signal Transduction Session (Session Chair) 3rd International Symposium on Microphysiometry and FLIPR Technology, Monterey, California, 1999
19. Reactive Oxygen Species as Second Messengers in the Kidney. Case Western Reserve University-Metro Health Medical Center, Division of Nephrology and Department of Physiology, 1999
20. G protein Signaling in Polarized Epithelial Cells. Invited Speaker, American Society of Nephrology Meeting, Miami Beach, Fla, 1999
21. Redox Signaling in the Kidney. University of Pittsburgh, Departments of Medicine and Physiology, 1999
22. Redox Signaling in the Kidney. Research Conference, The University of Louisville Kidney Disease Program, 1999
23. Role of Glomerular Mesangial Cells in Chronic Renal Failure. Invited Speaker, American Society of Nephrology Meeting, Montreal, Canada, 2000
24. Molecular and Clinical Aspects of Diabetes Insipidus. Case Western Reserve University-University Hospital Medical Center, Division of Nephrology and Department of Physiology, 2000
25. Role of Reactive Oxygen Species as Second Messengers. Symposium Organizer, American Society of Pharmacology and Experimental Therapeutics Meeting, Orlando, Florida, 2001
26. Unusual Signal Transduction Linkages of Serotonin Receptors. Vanderbilt University Department of Pharmacology, 2001
27. A Novel Pathway of Activation for Type I Sodium-Proton Exchangers. University of Minnesota Departments of Pharmacology and Psychiatry, 2002
28. CaM is a Modulator of GPCR Function. Case Western Reserve University Department of Biochemistry, 2005
29. Unexpected Roles for ESCRT Proteins in Receptor Recycling. Northwestern University Department of Pathology, 2011
 
International
1. The Study of Orphan Receptors Using Microphysiometry. British Pharmacological Society Symposium on Microphysiometry, London, England, 1995
2. Signal Transduction Session (Session Chair) 1st International Symposium on Microphysiometry and FLIPR Technology, Paris, France, 1997
3. The Study of G Protein Function using Microphysiometry. 1st International Symposium on Microphysiometry and FLIPR Technology, Paris, France, 1997
4. Unusual Signal Transduction Pathways of Serotonin Receptors. Invited Symposium Speaker and Session Chair, International Union of Pharmacologists Meeting, Rotterdam, the Netherlands, 1998
5. Free Radicals as Second Messengers in Chronic Renal Failure. Invited Speaker, International Society of Free Radical Biologists, Kyoto, Japan, 2000
6. Free Radical Scavengers as Possible Therapeutics for Chronic Renal Failure. Invited Speaker, Nippon Zoki Pharma, Osaka, Japan, 2000
7. Proteomic Methods in Signal Transduction. Invited Speaker, P. Universidad Católica de Chile, Santiago, Chile, 2001
8. Reactive Oxygen Intermediates as Signals in Kidney Cells. Invited Speaker, FONDAP Center for Cell Regulation and Physiology, Pucón, Chile, 2001
9. Regulation of 5-HT Function by Receptor Accessory Proteins. Serotonin Club Meeting, Kyoto, Japan, 2006
 
PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
1. RAYMOND, J.R., Regan, J.W., Beach, R.E., et al. (1987) Enrichment of alpha2-adrenergic receptors of rabbit proximal tubule basolateral membranes. Presented at the l9th Annual Meeting of the American Society of Nephrology, Kidney Int. 31:160, 12/1986
2. Beach, R.E., RAYMOND, J.R., Dennis V.W. (1987)., Mechanisms for adrenergic receptor stimulation of Na+-K+-ATPase activity in renal basolateral membranes. Presented at the l9th Annual Meeting of the American Society of Nephrology, Kidney Int. 31:178., 12/1986
3. RAYMOND, J.R., Saeed, M., Schwab, S.J. (1988) Enhancement of hemodialysis fistula patency: role of elective transluminal angioplasty. Proceedings of the 17th Scientific Session of the National Kidney Foundation, Washington D.C., 13A, 12/1987
4. RAYMOND, J.R., Saeed, M, Schwab, S.J. (1988) , Prospective detection and early treatment of venous stenoses in hemodialysis fistulas: a method of improving fistula patency. , Proceedings of the 18th Scientific Session of the National Kidney Foundation, Washington D.C., 18A, 12/1987
5. O'Connor, C.M., RAYMOND, J.R. (1988) Whipple's disease presenting as pulmonary hypertension: resolution of echocardiographic abnormalities with antibiotic therapy. Winning Clinical Vignette, Session of the American College of Physicians, New York, NY, 3/1988
6. RAYMOND, J.R., Fargin, A., Lohse, M., et al. (1989) The genomic clone G-21 encodes the human 5-HTlA receptor. Presented at the 21st Annual Meeting of the American Society of Nephrology, Dec. 1988. Kidney Int. 35:163, 12/1988
7. RAYMOND, J.R., Fargin, A.F., Caron, M.G., et al. (1989) Human 5-HTlA receptor stimulates Na+-PO4 transport in transfected HeLa cells. Presented at the Annual Meeting of the American Society for Clinical Investigation, Washington, D.C. Clin. Res. 37:584A, 4/1989
8. Fargin, A., RAYMOND, J.R., Regan, J.W., et al. (1989) Effector coupling mechanisms of the serotonin ( 5-HTlA) receptor. Presented at the Annual Meeting of the Association of American Physicians, Washington, D.C. Clin. Res. 37:586A, 4/1989
9. Dennis, V.W., Albers, F.J., Middleton, J.P., RAYMOND, J.R., (1990) PKA and PKC have opposite effects on phosphate transport in HeLa cells. Presented at the 22nd Annual Meeting of the American Society of Nephrology, Washington D.C., Kidney Int. 37:456, 12/1989
10. Albers, F.J., Dennis, V.W., Middelton, J.P, RAYMOND J.R. (1990) , Histamine H1 and serotonin 5-HTlA receptors expressed in HeLa cells stimulate phosphatidylinositol hydrolysis and phosphate uptake through distinct G proteins. , Presented at the 22nd Annual Meeting of the American Society of Nephrology, Washington D.C., Kidney Int. 37:453, 12/1989
11. Middleton, J.P., RAYMOND, J.R., Fargin, A., et al. (1990) Recombinant 5-HTlAreceptors stimulate Na+/K+-ATPase by a Ca2+-dependent pathway in HeLa cells. Presented at the 22nd Annual Meeting of the American Society of Nephrology, Washington D.C., Kidney Int. 37:567, 12/1989
12. RAYMOND, J.R., Fargin, A., Middleton, J.P. et al. (1990) , The cloned human 5-HTlA receptor expressed in HeLa cells stimulates sodium-dependent phosphate transport via protein kinase C. Presented at 22nd Annual Meeting of the American Society of Nephrology, Washington D.C., Kidney Int. 37:202, 12/1989
13. Albers, F.J., Middleton, J.P., Dennis, V.W., RAYMOND, J.R. (1990) , Somatostatin stimulates sodium-dependent phosphate uptake in HeLa cells: Evidence for a regulatory pathway independent of the inhibition of adenylate cyclase., Presented at the Annual meeting of the American Federation for Clinical Research, Washington, D.C. Clin. Res. 38:370A, 5/1990
14. RAYMOND, J.R., Middleton, J.P., Albers, F.J., Dennis, V.W. (1990) Thapsigargin stimulates sodium-dependent phosphate uptake in HeLa cells: evidence for a role of Ca2+, which is independent of PKC. Presented at the Annual meeting of the American Federation for Clinical Research, Washington, D.C. Clin. Res.38:244A, 5/1990
15. Middleton, J.P., RAYMOND, J.R., Whorton, A.R., Dennis V.W. (1990) , The cloned human 5-HTlA receptor stimulates Na+/K+-ATPase via activation of voltage sensitive calcium channels. Presented at the Annual meeting of the American Federation for Clinical Research, Washington, D.C. Clin. Res. 38:442A, 5/1990
16. Bates, M.D., Caron, M.G., RAYMOND, J.R. (1990) , Characterization and regulation of DA1 dopamine receptors in opossum kidney (OK) cells. , Presented at the 20th Annual Meeting of the Society for Neuroscience, St. Louis. Proceedings of the Society for Neuroscience 20:1., 11/1990
17. Albers, F.J., RAYMOND, J.R. (1990) , Serotonin "5-HTlD-like" Receptors inhibit cAMP generation in MDCK cells through a pertussis toxin-sensitive G protein. Presented at the 23rd Annual Meeting of the American Society of Nephrology, Washington D.C., J. Am. Soc. Nephrol. 1:465A, 12/1990
18. Bates, M.D., Caron, M.G., RAYMOND, J.R. (1990) Dynamic regulation of adenylyl cyclase-linked DA1 dopamine receptors in OK cells. Presented at the 23rd Annual Meeting of the American Society of Nephrology, Washington D.C., J. Am. Soc. Nephrol. 1:435, 12/1990
19. RAYMOND, J.R., Tisher, C.C. (1990) , Antipeptide antibodies to the human (serotonin) 5-HTlA receptor recognize renal receptors in thick ascending limb and distal convoluted tubule cells of rat and human kidney. , Presented at the 23rd Annual Meeting of the Amer-ican Society of Nephrology, Washington D.C., J. Am. Soc. Nephrol. 1 :729, 12/1990
20. Dennis, V.W., Albers, F.J., Collinsworth, G.G., Cotecchia, S., RAYMOND, J.R., Middleton, J.P. (1990) , Recombinant alphalB adrenergic receptors increase Na+-PO4 co-transport by PKC- dependent & -independent pathways in HeLa cells. , Presented at the 23rd Annual Meeting of the American Society of Nephrology, Washington D.C., J. Am. Soc. Nephrol. 1:468, 12/1990
21. RAYMOND, J.R., Middleton, J.P. (1991) Recombinant human 5-HTlA receptors in CHO cells couple to multiple signal transduction pathways. Presented at the Annual meeting of the American Federation for Clinical Research, Seattle, Washington, Clin. Res 39:358, 5/1991
22. RAYMOND, J.R. (1990) Phorbol 12-myristate, 13-acatate induces rapid phosphorylation and desensitization of recombinant 5-HTlA receptors expressed in CHO cells. Presented at the Annual meeting of the American Federation for Clinical Research, Seattle, Washington, Clin. Res 39:343. Winner of Henry Christian Award for Research Excellence, 5/1991
23. Liggett, S.B., RAYMOND, J.R., Chesnut, L.C., Caron, M.G., Lefkowitz, R.J. (1991) Role of the beta-adrenergic receptor kinase in desensitization of the a2-adrenoceptor. Presented at the Annual meeting of the American Federation for Clinical Research, Seattle, Washington, Clin.Res 39:342A, 5/1991
24. Albers, F.J., RAYMOND, J.R., Dennis, V.W., Middleton, J.P. (1991) Amplification of cAMP signaling cascade in opossum kidney cells. Presented at the Annual meeting of the American Federation for Clinical Research, Seattle, Washington, Clin. Res 39:180A, 5/1991
25. Nash, S.R., Fornaretto, M.G., Bates, M.D., RAYMOND, J.R.,Caron, M.G. (1991) , Cloning and sequence of a dopamine receptor from opossum kidney cells that is expressed in kidney and brain. Presented at 21st Annual meeting of Society for Neuroscience, New Orleans. , Proceedings of the Society for Neuroscience 21:551A., 11/1991
26. Liu, J., RAYMOND, J.R., Tamir, H., Millhorn, D., Lauder, J.M. (1991), Embryonic glial cells express 5-HT receptors and exhibit regional differences in neuronotrophic activity in response to 5-HT. Presented at 21st Annual meeting of Society for Neuroscience, New Orleans, 11/1991
27. Mangell, A., RAYMOND, J.R., Fitz, J.G. (1991) Recombinant 5-HTlA receptor provides evidence for Gi modulation of Gs-stimulated large-conductance Cl- current in CHO cells: A regulatory system analogous to adenylyl cyclase. , Presented at the 24th Annual Meeting of the American Society of Nephrology, Baltimore, MD, J. Am. Soc. Nephrol. 2:458A, 11/1991
28. Becker, B.N., Lee, S.-J., Fanburg, B.L. RAYMOND,J.R. (1992) , Bovine pulmonary artery smooth muscle cells express 5-HT4 receptors which stimulate adenylyl cyclase. , Presented at the Annual Meeting of the Southern Section of the American Federation for Clinical Research, New Orleans. Clin. Res 39:831A., 1/1992
29. RAYMOND, J.R., Albers, F.J., Middleton, J.P., Becker, B.N., Bates, M.D. (1992) , Stable functional expression of rat phosphodiesterase type 3 cDNA in OK cells does not alter short-term homologous desensitization of native DA1 dopamine receptors. , Presented at the Annual meeting of the American Federation for Clinical Research, Baltimore, Maryland, Clin. Res 40:217A., 5/1992
30. RAYMOND, J.R., Albers, F.J., Middleton, J.P., Becker, B.N., Bates, M.D. (1992) Stable expression of rat phosphodiesterase 3 cDNA in OK cells does not alter short-term homologous desensitization of DA1 dopamine receptors. , Presented at the Annual meeting of the American Federation for Clinical Research, Baltimore, Maryland, Clin. Res 40:217A, 5/1992
31. Becker, B.N., Mulheron, J., Gettys, T.W., Lee, S.-L., Fanburg, B.L., RAYMOND, J.R. (1992) Differential phenotypic expression of 5-HT-coupled adenylylcyclase activity in vascular smooth muscle cells. Presented at 23rd Annual Meeting of American Society of Nephrology, Baltimore, J. Am. Soc. Nephrol. 3:485A, 11/1992
32. RAYMOND, J.R., Olsen, C.L., Gettys, T.W. (1992) Physical & functional coupling of recombinant human 5-HT1A receptors to multiple subtypes of Gi in mammalian cells. Presented at 25th Annual Meeting of the American Society of Nephrology, Baltimore, J. Am. Soc. Nephrol. 3:485A, 11/1992
33. Becker, B.N., Lee, S.-L., Fanburg, B.L., Raymond, J.R. (1992) Becker, B.N., Lee, S.-L., Fanburg, B.L., RAYMOND, J.R. (1992) Gs Coupled vascular smooth muscle 5-HT4-like receptors rapidly desensitize. Presented at 23rd Annual Meeting of American Society of Nephrology, Baltimore, J. Am. Soc. Nephrol. 3:485A, 11/1992
34. Gettys, T.W., Fields, T.A., RAYMOND, J.R. (1993) , Partial agonists of the human 5-HT1A receptor selectively activate Gia-2 and Gia-3 with less efficacy than full agonists. , Presented at the 23rd Annual Meeting of the American Society for Biochemistry and Molecular Biology, San Diego, FASEB J. 7:A1138, 6/1993
35. Kirchgessner, A.L., Liu, M.-T., RAYMOND, J.R., Gershon, M.D. (1993). , Immunohistochemical detection of 5-HT1A receptors in rat bowel and pancreas. Presented at 23rd Annual meeting of Society for Neuroscience, New Orleans. , Proceedings of the Society for Neuroscience 23:523A., 11/1993
36. RAYMOND, J.R., Casañas, S.J., Mulheron, J.G., Garnovskaya, M.N., Arthur, J.M. Gettys, T.W. (1993) , Human Serotonin 5-HT1A receptors activate endogenous Go-like GTP binding protein(s) when heterologously expressed in insect cells. , Presented at 26th Annual Meeting of American Society of Nephrology, Boston, J.Am.Soc. Nephrol. 4:497A, 11/1993
37. Arthur, J.M., Gettys, T.W., RAYMOND, J.R. (1994) Cell specific partial agonism of a 5-HT1A receptor ligand. Presented at the Annual FASEB meeting, San Diego, Cal. FASEB J.:A87 1994, 3/1994
38. Nebigil, C., RAYMOND, J.R., Spurney, R.F., Garnovskaya, M.N. (1994) Molecular cloning and multiple second messenger pathways of a 5-HT2 receptor expressed in rat mesangial cells. Presented at the Annual FASEB Meeting, San Diego, Cal. FASEB J. 8:A87, 3/1994
39. RAYMOND, J.R., Nebigil, C.G., Gettys, T.W., Arthur, J.M., Garnovskaya, M.N. (1994) Interaction of an endogenous receptor kinase with human 5-HT1A receptors in insect cells. Presented at the Annual Meeting of the American Federation for Clinical Research, Baltimore, Maryland, Clin. Res, 5/1994
40. Gettys, T.W., Arthur, J., RAYMOND, J.R., Taylor, I.L., Olah, M. (1994) Physical and functional coupling of transfected A1-adenosine receptors to inhibitory G proteins in Chinese hamster ovary cells. Presented at the 5th Annual Adenosine Symposium, Washington, D.C., 5/1994
41. Arthur, J.M., Collinsworth, G.P., Quarles, L.D., Raymond, J.R.(1995) MDCK cells possess a polycation receptor that activates G proteins from the Gi-alpha & Gq-alpha families. Presented at Annual Meeting of the American Federation for Clinical Research, San Diego, J. Invest. Med. 43:263A, 1995. Winner of Henry Christian Award for Research Excellence, 5/6/1995
42. Liu, X., Gao, Y., Garnovskaya, M.N., RAYMOND, J.R., Kebabian, J.W. (1995) Novel molecular probes for the 5-HT1A receptor. Presented at the 210th Annual Meeting of the American Chemical Society, Chicago, IL, 8/1995
43. Prpic, V., Garnovskaya, M.N., Fitz, J.G., Gettys, T.W., Collinsworth, G.P, RAYMOND, J.R., Liddle, R.A. (1995) Bombesin stimulates proton efflux and CCK secretion in STC-1 cells. Presented at 9th International Conference on Second Messengers and Phosphoproteins, Nashville, Tennessee. Abstract 371, page 132 of Conference Proceedings, 10/1995
44. Gao, Y., Liu, X., RAYMOND, J.R., Garnovskaya, M.N., Kebabian, J.W. (1995) Interactions of (S)-UH-301 derivatives with recombinant 5-HT1A receptors. Presented at the Annual Meeting of the Society for Neuroscience, San Diego, 11/1995
45. Arthur, J.M., Collinsworth, G.P., Ramos, S.J.C., Gettys, T.W., RAYMOND, J.R. (1995) Bradykinin causes translocation of G-alpha-q from membrane to cytosol in Madin-Darby canine kidney cells. Presented at 68th Annual Scientific Sessions of the American Heart Association, Anaheim, Circulation 92(suppl 1):I-573 1995, 11/1995
46. Arthur, J.M., Collinsworth, G.P., Ramos, S.J.C., Gettys, T.W., RAYMOND, J.R. (1995) ., Stimulation of a polycation sensing receptor in MDCK cells causes translocation from the membrane of G-alpha-q but not G proteins of the Gi-alpha family. , Presented at the 28th Annual Meeting of the American Society of Nephrology, San Diego, J. Am. Soc. Nephrol. 6:783 1995, 11/1995
47. Mannon, R.B., Mannon, P.J., Lindman, B., RAYMOND, J.R., Platt, J.L., Coffman, T.M. (1995) Thromboxane receptor expression and signaling in thymus. Presented at the 28th Annual Meeting of the American Society of Nephrology, San Diego, J. Am. Soc. Nephrol. 6:841, 11/1995
48. Garnovskaya, MN, van Biesen, T., Hawes, B., Lefkowitz, R.J., RAYMOND, J.R. (1996) Specific alpha subunits derived from the Gi/o/z family mediate acute agonist-induced activation of NHE. Presented at the 29th Annual Meeting of the American Society of Nephrology, New Orle, 11/1996
49. Mannon, R.B., Mannon, P.J., Ferri, K., RAYMOND, J.R., Coffman, T.M. (1996) Thromboxane receptors are expressed and mediate apoptosis in EL4 thymoma cells. Presented at the 29th Annual Meeting of the American Society of Nephrology, New Orleans, 11/1996
50. Garnovskaya, MN, van Biesen, T., Hawes, B., Lefkowitz, R.J., RAYMOND, J.R. (1996) Divergent pertussis toxin-sensitive pathways for 5-HT1A receptor activation of NHE and ERK. Presented at the 29th Annual Meeting of the American Society of Nephrology, New Orleans, 11/1996
51. RAYMOND, J.R., Garnovskaya, M.N. (1996) Regulation of NHE-1 activity via Gi proteins. Presented at the 1996 Annual Meeting of the Southern Kidney, Salt and Water Club, Longboat Key, Florida., 12/1996
52. Wang, Y., Roman, R. RAYMOND, J.R., Fitz, J.G. (1996) Metabolic stress opens K+ channels in biliary cells through activation of protein kinase C alpha. Presented at the Annual Hepatology Meeting, 1996
53. Greene, E.L., Collinsworth, G., Garnovskaya, M.N., Grewal, J., Sajjad, T., RAYMOND, J.R. (1997) Receptor activation of MAP kinases ERK1/ERK2 occurs by an anti-oxidant-sensitive mechanism. Presented at the 1997 Annual Meeting of the California Oxidant Society, 2/1997
54. Greene, E.L., Collinsworth, G., Garnovskaya, M.N., RAYMOND, J.R. (1997) Renal mesangial cell 5-HT2A receptor activates mitogen-activated protein kinases ERK1/ERK2 by an anti-oxidant-sensitive pathway. , Presented at the Annual meeting of the American Society for Clinical Investigation, Washington, DC, J. Investigative. Med. 45:232S, 4/1997
55. Paul, R.V., Wackym, P.S., RAYMOND, J.R., Ullian, M.E. (1997), Angiotensin II shortens natriuretic peptide C-receptor mRNA half-life in vascular smooth muscle cells through a transcription-dependent mechanism., Presented at 30th Annual Meeting of the American Society of Nephrology, 1997
56. Lauder, J.M., Lubin, D., Meter, K., Wilkie, M., RAYMOND, J.R., Grayson, D.R., Liu, J., Johns, J.J. (1997) Prenatal cocaine alters postnatal expression of 5-HT1A receptors in developing rat brain. Presented at the Annual Meeting of the Society for Neuroscience, 1997
57. Mukhin Y., Della Rocca G., RAYMOND J.R., Garnovskaya M.N.(1998) Involvement of calmodulin in 5- HT1A receptor-activation of mitogen activated protein kinase and Na+/H+ exchange in fibroblasts. Presented at Annual FASEB Meeting, San Francisco, FASEB J. 12: A745, 3/1998
58. Garnovskaya M.N., Mukhin Y.V., Ullian M.E., RAYMOND J.R. (1998) Mitogen-induced activation of Na+/H+ exchange in vascular smooth muscle cells involves Janus kinase. Presented at the Annual FASEB Meeting, San Francisco, FASEB J. 12:A744, 3/1998
59. RAYMOND J.R., Collinsworth G.P., Mukhin Y.V., Garnovskaya M.N. (1998) Evaluating unusual G protein-coupled signals with the Cytosensor™. Presented at the Second International Cell Analysis Products Users Meeting, Hilton Head, S.C., 5/1998
60. Garnovskaya M.N., Collinsworth G.P., RAYMOND J.R., Ploth D.W.(1998) Multiple receptors activate Na+/H+ exchange in mIMCD-3 cells. Presented at the Second International Cell Analysis Products Users Meeting, Hilton Head, S.C., 5/1998
61. Mukhin Y.V., Ullian M.E., RAYMOND J.R., Garnovskaya M.N. (1998) Mitogens use different pathways to activate Na+/H+ exchange in vascular smooth muscle cells. Presented at the Second International Cell Analysis Products Users Meeting, Hilton Head, S.C., 5/1998
62. Garnovskaya, M.N., Collinsworth, G., RAYMOND, J.R., Fitzgibbon, W., Paul, R.V., and Ploth, D.W.(1998) Bradykinin B2 rceptor activation increases Na+/H+ exchange in mIMCD-3 cells. Presented at 31st Annual Meeting of the American Society of Nephrology. J. Am. Soc. Nephrol. 9:6A, 1998
63. Chen, R., Greene, E.L., Collinsworth, G., Grewal, J., Houghton, O., Zeng, H., Paul, R.V., RAYMOND, J.R. (1998) Enrichment of transiently transfected mesangial cells by co-transfection with GFP. Presented at 31st Annual Meeting of the American Society of Nephrology. J. Am. Soc. Nephrol. 9:436A, 1998
64. Grewal, J., RAYMOND, J.R., Greene, E.L.(1998) , Serotonin 5-HT2A receptor induces TGF-beta1 mRNA and protein in rat mesangial cells via ERK. Linkage between proliferative and fibrotic signals. Am. J. Physiol. 276:F922-F930. , Presented at the 31st Annual Meeting of the American Society of Nephrology. J. Am. Soc. Nephrol. 9:422A., 1998
65. Jaffa, A.A., Kappler, C.S., Collinsworth, G., Raymond, J.R., Fitzgibbon, W.R., and Ploth, D.W. (1998) Bradykinin activates ERK1/2 in mIMCD3 cells through B2 receptors. Presented at 31st Annual Meeting of the American Society of Nephrology. J. Am. Soc. Nephrol. 9:425A, 1998
66. Garnovskaya M.N., Mukhin Y.V., RAYMOND J.R. (1999) Role for Janus kinase in the activation of sodium-hydrogen exchange by osmotic shock. Presented at the Miami Nature Biotechnology Winter Symposia, Miami, FL, MNB Short Reports 10:37, 2/6/1999 - 2/10/1999
67. Mukhin Y.V., Garnovskaya M.N., Collinsworth G.P., Greene E.L., and RAYMOND J.R. (1999) 5-HT1A receptor stimulate extracellular signal-regulated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of Src in CHO-K1 fibroblasts. , Presented at the Miami Nature Biotechnology Winter Symposia, Miami, FL, MNB Short Reports 10:43, 2/6/1999 - 2/10/1999
68. Mukhin Y.V., Collinsworth G.P., Fitzgibbon, W., Ploth, D.W., RAYMOND J.R. Garnovskaya M.N. (1999) Bradykinin B2 receptor activation increase Na+/H+ exchange in mIMCD-3 cells. Presented at the Annual FASEB Meeting, Washington, DC, FASEB J. 13:A135, 3/1999
69. RAYMOND J.R., Mukhin Y.V., Reilly C., Collinsworth G.P., and Garnovskaya M.N. (1999) Use of the Cytosensor and FLIPR to probe methabolic pathways. Presented at the Third International Cell Analysis Products Users Meeting, Monterey, CA., 5/1999
70. Garnovskaya M.N., Mukhin Y.V., Collinsworth G.P., Fitzgibbon, W., RAYMOND J.R., and Ploth, D.W. , Characterization of bradykinin B2 receptors in inner medullary collecting duct cells with FLIPR and Cytosensor™ microphysiometer. Presented at 3rd International Cell Analysis Products Users Meeting, Monterey, CA., 5/1999
71. Mukhin Y.V., Bell J., Collinsworth G.P., RAYMOND J.R., Ploth, D.W., and Garnovskaya M.N. (1999) The use of FLIPR and Cytosensor to study bradykinin-induced cellular responses in M-1 cortical collecting duct cells. Presented at 3rd International Cell Analysis Products , Monterey, CA., 5/1999
72. Chen R., Paul R.V., Garnovskaya M.N., Mukhin Y.V. RAYMOND J.R., and Ullian M.E. (1999) , A functional angiotensin type 1 receptor-GFP fusion protein. Presented at 53rd Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 9/13/1999 - 9/16/1999
73. Chen, R., Huang, C., RAYMOND, J.R., and Paul, R.V. (1999) Blockade of TGF-beta effects on mesangial cells by overexpression of Smad7. Presented at 32nd Annual Meeting of the American Society of Nephrology. Miami, J. Am. Soc. Nephrol. 10:452A, 11/1999
74. Budisavljevic, M.N., Fullmer, J.R., Self, S.E., RAYMOND, J.R., Kuhlmann, M.K., and Greene, E.L. (1999) The antioxidant, alpha-lipoic acid ameliorates cellular proliferation and ERK phosphorylation in anti-Thy1 nephritis. Presented at 32nd Annual Meeting of the American Society of Nephrology. Miami, FL, J. Am. Soc. Nephrol. 10:543-544A, 11/1999
75. Andy, J.C., Grewal, J.S., Greene, E.L., Garnovskaya, M.N., Mukhin, Y.V., Collinsworth, G., and RAYMOND, J.R.(1999) Indoxyl sulfate stimulates phosphorylation of ERK in cultured rat mesangial cells. Presented at 32nd Annual Meeting of the American Society of Nephrology. Miami, FL, J. Am. Soc. Nephrol. 10:543-544A, 11/1999
76. Garnovskaya M.N., Mukhin Y.V., RAYMOND J.R. (1999) Angiotensin II and serotonin induce the phosphorylation of serine 727 of STAT3 in vascular smooth muscle cells. Presented at Annual FASEB Meeting, Washington, DC, FASEB J. 13:A468, 1999
77. Garnovskaya, M., Mukhin, Y., Collinsworth, G., Ulian, M., RAYMOND, J.R.(2000) The role of the Na+/H+ exchanger in the mitogen-induced activation of extracellular signal regulated protein kinase in vascular smooth muscle cells. Presented at Annual FASEB Meeting, San Diego, FASEB J. 14:A592(442.29), 4/2000
78. Mukhin, Y., Garnovskaya, M., Collinsworth, G., Fitzgibbon, W., RAYMOND, J.R., Ploth, D.W.(2000) Bradykinin Stimulates a complex formation between calmodulin and Janus kinase in mIMCD-3 cells. Presented at Annual FASEB Meeting, San Diego, CA, FASEB J. 14:A589 (442.16), 4/2000
79. Chen, R., Mukhin, Y.V., Garnovskaya, M.N., RAYMOND, J.R., and Paul RV(2000) Use of rhodamine-angiotensin II conjugate to trace the angiotensin receptor. Presented at the Annual FASEB Meeting, San Diego, CA, FASEB J.14:A724 (499.18), 4/2000
80. Turner, J.H., Mukhin, Y.V., Garnovskaya, M., Collinsworth, G., RAYMOND, J.R. (2000) Hyperosmotic-induced mechanisms of pH recovery in the inner medullary collecting duct. Presented at the 4th Annual Symposium on Cellular Fluorescence, Napa, CA, 5/2000
81. Mukhin, Y., Garnovskaya, M., Collinsworth, G., Fitzgibbon, W., RAYMOND, J.R., Ploth, D.(2000) Bradykinin stimulates NHE through calmodulin and jak2 in mIMCD-3 cells. Presented at 4th Annual Symposium on Cellular Fluorescence, Napa, CA, 5/2000
82. Garnovskaya M., Mukhin Y., Collinsworth G., Ulian M., RAYMOND J.R. (2000) , Na+/H+ exchanger is required for activation of the mitogen and extracellular signal regulated protein kinase in vascular smooth muscle cells., Presented at the 4th Annual Symposium on Cellular Fluorescence,Napa, CA, 5/2000
83. Mukhin Y., Vlasova T., Grewal J., Ulian M., Tholanikunnel B., RAYMOND, J.R., and Garnovskaya M. (2001) ERK is an Intermediate for Rapid Phosphorylation of Serine795 of the Retinoblastoma Gene Product in Vascular Smooth Muscle Cells. Presented at Annual FASEB Meeting, Orlando, FL; FASEB J. 15:A205 (193.10), 4/2001
84. Grewal. J., RAYMOND, J.R. (2001) GPCRs desensitize and down regulate EGF receptors in renal mesangial cells. Presented at Annual FASEB Meeting, Orlando, FL; FASEB J. 15:A180 (180.11), 4/2001
85. Turner, J., Gelasco, A., RAYMOND, J.R.(2001) Use of Tryptic Fingerprinting to Identify NHE-1-associated Proteins. Genomics and Proteomics in Kidney and Urologic Diseases sponsored by NIDDK; Washington, DC, 7/8/2001 - 7/10/2001
86. Lefler, D.M., Collinsworth, G., Mukhin, Y.V., Garnovskaya, M.N., RAYMOND, J.R. (2001) Jak2 and calmodulin are critical mediators of bradykinin 2 receptor activation of Na+/H+ exchange in three cell lines. Presented at the ASN/ISN World Congress of Nephrology, San Francisco., 10/2001
87. Mukhin, Y.V., Garnovsky, E.A., RAYMOND, J.R, Garnovskaya, M.N. (2002) Bradykinin B2 receptor activates ERK in mIMCD3 cells via epidermal growth factor transactivation. Presented at annual FASEB Meeting, New Orleans; FASEB J 16:A171 (158.19), 4/2002
88. Mukhin, Y.V., Garnovsky, E.A., Raymond, J.R., Garnovskaya MN.(2002) Bradykinin B2 receptor activates ERK in renal cells via EGFGR transactivation. Presented at 16th International Conference KININ 2002, Charleston, SC; MUSC: Program and Abstracts, 2002; 63 (P-21), 5/2002
89. Garnovskaya, M.N., Mukhin, Y.V., RAYMOND, J.R.(2002) The mechanism of Epidermal Growth Factor receptor transactivation by bradykinin B2 receptor in mIMCD-3 cells. Presented at 16th International Conference KININ 2002, Charleston, SC; MUSC: Program and Abstracts, 2002; 62 (P-20), 5/2002
90. Mukhin, Y.V., RAYMOND, J.R, Garnovskaya M.N. (2003) Novel mechanism of EGF receptor transactivation by bradykinin B2 receptor in kidney cells. Presented at annual FASEB Meeting, San Diego, CA. FASEB J 17: A1013 (635.04), 4/2003
91. Turner, J.H., Garnovskaya, M.N., Mukhin, Y.V., RAYMOND, J.R.(2003) Regulation of the type 1 Na+/H+ exchanger by Janus kinase and Ca2+/calmodulin. Presented at annual FASEB Meeting, San Diego; FASEB J 17: A1029 (647.10), 4/2003
92. Garnovskaya, M.N., Mukhin, Y.V., RAYMOND, J.R. (2003) The Na+/H+ exchanger regulates mitogen-activated protein kinase upstream of Ras in vascular smooth muscle cells. Presented at annual FASEB Meeting, San Diego. FASEB J 17:A1016 (635.20), 4/2003
93. Nazeer, K., Kandasamy, K., Self, S., Smith, A., Fitzgibbon, W., RAYMOND, J.R. (2003) Treatment with the anti-oxidant, alpha-lipoic acid, attenuates fibrosis in unilateral ureteral obstruction. American Society of Nephrology Renal Week, San Diego. JASN 14:118A (F-PO249), 10/2003
94. Göoz, M., Mukhin, Y., RAYMOND, J.R, Garnovskaya, M.N.(2003) Involvement of TACE in 5-HT induced ERK phosphorylation and HB-EGF shedding in mesangial cells: possible role in kidney fibrosis and cancer. Presented at 44th Annual Meeting of Southern Salt, Water, and Kidney Club, Sarasota, FL, 12/3/2003 - 12/7/2003
95. Turner, J.H., RAYMOND, J.R. (2003) Interaction of calmodulin with G protein-coupled receptors. Presented at 44th Annual Meeting of Southern Salt, Water, and Kidney Club. Sarasota, FL, 12/3/2003 - 12/7/2003
96. Mukhin, Y., RAYMOND, J.R, Garnovskaya, MN.(2003) Bradykinin activates two distinct proton efflux pathways in M-1 cells. Presented at 44th Annual Meeting of Southern Salt, Water, and Kidney Club. Sarasota, FL, 12/3/2003 - 12/7/2003
97. Turner, J.H., RAYMOND, J.R.(2004) , Interaction of Ca2+/calmodulin with the third intracellular loop of the serotonin 5-HT1A receptor modulates receptor phosphorylation by protein kinase C. Presented at the annual FASEB Meeting, Washington, DC; FASEB J 18: (639.2), 4/2004
98. Ayiku, H., Bland, A., D'Engenio, L., Arthur, J., RAYMOND, J.R, Turner, J.(2004) A proteomic approach for the identification of sodium/proton exchanger (NHE-1) Interacting Proteins. American Society of Nephrology Regional Meeting. Louisville, KY, 10/31/2004 - 11/1/2004
99. Ayiku, H., Bland, A., D'Eugenio, L., Arthur, J., Turner, J.H., RAYMOND, J.R.(2004) Identification of sodium proton exchanger (NHE-1) interacting proteins. American Society of Nephrology Renal Week October, 2004, St. Louis, MO. JASN 15 (SU-PO038), 10/2004
100. Morinelli, T.A., RAYMOND, J.R, Göoz, M., Ullian, M.E.(2004) Internalization of the angiotensin II type 1a receptor (AT1aR) is mediated by calmodulin (CaM). American Society of Nephrology Renal Week, St. Louis, MO. JASN 15 (SA-PO462), 10/2004
101. Ayiku, H., Bland, A., D'Eugenio, L., Turner, J.H., RAYMOND, J.R, Arthur, J. (2005) Use of proteomic methods to identify sodium proton exchanger (NHE-1) interacting proteins. Southern Society of Clinical Investigation. New Orleans, LA, 2/2005
102. Mukhin, Y.V., RAYMOND, J.R, Ploth, D.W., Garnovskaya, M.N.(2005) Small GTP-binding proteins differentially regulate bradykinin-induced H+ effluxes in mIMCD-3 and M-1 cells. Presented at the annual FASEB Meeting, San Diego; FASEB J 19: (314.11), 4/2005
103. Garnovskaya, M.N., Gooz, M., Mukhin, Y.V., RAYMOND, J.R.(2005) Bradykinin B2 receptor-induced ERK activation in kidney cells involves integrins. Presented at the annual FASEB Meeting, San Diego; FASEB J 19:(876.6), 4/2005
104. Morinelli, T.A., RAYMOND, J.R, Ullian, M.E.(2005) Potential nuclear localization motif within Angiotensin II type 1a receptor. American Society of Nephrology Renal Week, Philadelphia, PA. JASN 16:379A (F-PO193), 11/2005
105. Varghese, S.A, Powell, T.B., Budisavljevic, M.N., Oates, J.C., RAYMOND, J.R., Almeida, J.S., Arthur, J.M.(2006) Identification of Glomerular Diseases Based on the Pattern of Charge and Size of Urinary Proteins. Presented at US HUPO meeting, Boston, MA, 3/13/2006
106. Baldys, A., RAYMOND, J.R.(2006) Role of protein kinase C in epidermal growth factor receptor trafficking in HEK293 cells. Presented at the annual FASEB Meeting, San Francisco; FASEB J 20:A115 (102.13), 4/2006
107. Coaxum, S.D., Gooz, M., Baldys, A., Garnovskaya, M.N., RAYMOND, J.R.(2006) Epidermal growth factor activates Na+/H+ exchanger in podocytes through a mechanism that involves janus kinase 2 and calmodulin. Presented at the annual FASEB Meeting, San Francisco; FASEB J 20: A764, (472.25), 4/2006
108. Gooz, M., Gooz, P., RAYMOND, J.R.(2006) Crosstalk between 5-HT2A receptor and EGFR involves integrins. Presented at the annual FASEB Meeting, San Francisco; FASEB J 20:A247 (171.7), 4/2006
109. Göoz M, Göoz P, RAYMOND, J.R., Luttrell L.M.(2006) alpha-V and beta-1 integrins mediate 5-HT2A receptor-EGFR cross-talk. Presented at the American Society for Matrix Biology Biennial National Meeting, Nashville, Tennessee, 11/1/2006 - 11/4/2006
110. Velez, J.C.Q., Bland, A.M., RAYMOND, J.R., Janech, M.G.(2006) Differential pattern of peptide generation from Angiotensin substrates in resident glomerular cells. American Society of Nephrology Renal Week, San Diego. JASN 17:SA-PO783, 11/2006
111. Idkowiak-Baldys, J., Baldys, A., RAYMOND, J.R., Hannun, Y.A.(2006), Agonist activation of G-protein coupled Receptors (GPCRs) induces formation of the protein kinase C (PKC)-dependent pericentrion. 41st Annual Southeastern Regional Lipid Conference. Cashier NC, 11/2006
112. Gooz, M, Gooz, P, Twal, W.O., Rocha, C.L., Luttrell, L.M., RAYMOND, J.R.(2007) Fibronectin activates ADAM17/TACE by competing with alpha-5-beta-1 integrin binding. 3rd Annual GPCR Colloquium, Washington DC, 4/27/2007 - 4/28/2007
113. Morinelli, T.A., Baldys, A, RAYMOND, J.R. and Ullian M.E.(2007), The role of angiotensin II (AII) AT1AR internalization in the angiotensin II-induced expression of cyclooxygenase 2 COX-2) in rat aortic vascular smooth muscle cells., 3rd Annual GPCR Colloqium,Washington DC , 4/27/2007 - 4/28/2007
114. Gooz, M, Gooz, P, Twal, W.O., Luttrell, L.M., RAYMOND, J.R.(2007) 5-HT induces disassembly of TACE/beta-one integrin complex and promotes co-immunoprecipitation of EGFR/beta3integrin during 5-HT2A receptor-EGFR cross-talk. FASEB Meeting, Washington, DC, 4/28/2007 - 5/2/2007
115. Rocha, C.L., RAYMOND, J.R., Gooz, M.B.(2007) ADAM-17-dependent transactivation of EGFR by 5-HT2 is mediated by Src and PI3K in rat mesangial cells. FASEB Meeting, Washington DC, 4/28/2007 - 5/2/2007
116. Kramarenko, I., Bunni, M., RAYMOND, J.R., Garnovskaya M.N. (2007), Bradykinin B2 receptor interacts with integrin alpha-5/beta-1 to transactivate epidermal growth factor receptor in kidney cells. , Presented at the Scientific Session of the American Heart Association, Orlando FL , 11/4/2007 - 11/7/2007
117. Bunni, M., Kramarenko, I., RAYMOND, J.R., Garnovskaya M.N.(2007) Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells. Presented at the Scientific Session of the American Heart Association, Orlando FL, 11/4/2007 - 11/7/2007
118. Velez, J.C.Q., Bunni, M, Janech, M.G., RAYMOND, J.R.(2007) Angiotensin-(1-7) and angiotensin-(1-9) oppose angiotensin-II effects in human mesangial cells. Presented at the American Society of Nephrology Renal Week, San Francisco, 11/2007
119. Velez, J.C.Q., Arthur, J.M., Bland, A., Budisavljevic, M., Fitzgibbon, W.R., Amani, Z., RAYMOND, J.R., Janech, M.G.(2007) Angiotensin metabolite formation identified by mass spectrometry in isolated glomeruli. Presented at the American Society of Nephrology Renal Week, San Francisco, 11/2007
120. Idkowiak-Baldys, J., Baldys, A., Chu, W., Zhang, Z.-R., Bell, P.D., RAYMOND, J.R., Hannun, Y.A. 2007)Serotonin induces classical protein kinase C (cPKC)-dependent formation of pericentrion. Presented at 42nd Annual Southeastern Regional Lipid Conference, Cashiers NC, 11/2007
121. Garnovskaya, M.N., Bunni, M., Kramerenko, I., RAYMOND, J.R., Morinelli, T.A.(2008) Bradykinin B2 receptor induces multiple cellular responses leading to proliferation of renal carcinoma cells. Presented at the Experimental Biology Meeting, San Diego, 4/5/2008 - 4/9/2008
122. Kramarenko, I., Bunni, M., RAYMOND, J.R., Garnovskaya, M.N.(2008) Identification of a functional bradykinin B2 receptor expressed in HEK293 cells. Presented at the Experimental Biology Meeting, San Diego, 4/5/2008 - 4/9/2008
123. Coaxum, S.D., RAYMOND, J.R.(2008) Mutations in the i3N loop calmodulin-binding of the 5-HT1A receptor attenuates Erk activation. Presented at the Experimental Biology Meeting, San Diego, 4/5/2008 - 4/9/2008
124. Zhang, Z-R., Chu, W.-F., Komlosi, P., Baldys, A., Haycraft, C.J., RAYMOND, J.R., Bell, P.D. (2008) Altered regulation of ion channel activity by EGF in polycystic kidney disease. Presented at the Experimental Biology Meeting, San Diego, 4/5/2008 - 4/9/2008
125. Gooz, M., Rocha, C.L., Bell, L.H., Gooz, P., Luttrell, L., RAYMOND, J.R.(2008) 5-HT induces threonine (T735) phosphorylation of ADAM17/TACE cytoplasmic tail. FASEB Meeting, San Diego, 4/5/2008 - 4/9/2008
126. Gooz, M., Gooz, P., Twal, W.O., Luttrell, L.M., RAYMOND, J.R.(2007) 5-HT induces disassembly of TACE/integrin complex and promotes co-mmunoprecipitation of EGFR/beta3-integrin during 5-HT2A receptor-EGFR cross-talk. Presented at NIDDK symposium:, "Career Development Symposium: Life after K", Washington DC, 6/2008
127. Velez, J.C., Ryan, K., Bland, A., Budisavljevic, M.N., Fitzgibbon, W.R., RAYMOND, J.R., Arthur, J.A., Janech, M.G. (2008) Generation of Angiotensin-(1-7) and Angiotensin-(2-10)in Intact Rat glomeruli analyzed by MALDI-TOF MS. Presented at 62nd High Blood Pressure Research Conference, Atlanta, 9/17/2008 - 9/20/2008
128. Velez, J.C., Morinelli, T.A., Walker, L.A., Bunni, M., Arthur, J.M., RAYMOND, J.R., Ullian, M.E., Janech, M.G.(2008)Angiotensin-(2-10) is actively formed by glomerular cells and signals through the AT1a receptor. Presented at the American Society of Nephrology Renal Week, Philadelphia, 11/4/2008 - 11/9/2008
129. Dey, M., RAYMOND, J.R., Gooz, M.(2009) Role of ADAM17 in bradykinin-induced EGF receptor activation in glomerular podocytes. Presented at the Experimental Biology Meeting, New Orleans, 4/18/2009 - 4/22/2009
130. Zhang, Z.-R., Chu, W.-F., Song, B., Gooz, M., Baldys, A., Kolb, R.J., Steele, S., Houston, A., Haycraft, C.J., Owsianik, G., Nilius, B., RAYMOND, J.R., Komlosi, P., Bell, P.D.(2009) EGFR augments cell proliferation in polycystic kidney disease through activation of a novel ion channel. Presented at Experimental Biology Meeting, New Orleans, 4/18/2009 - 4/22/2009
131. Zhang, Z.-R., Chu, W.-F., Song, B., Gooz, M., Baldys, A., Kolb, R.J., Steele, S., Houston, A., Haycraft, C.J., Owsianik, G., Nilius, B., RAYMOND, J.R., Komlosi, P., Bell, P.D.(2009) EGFR augments cell proliferation in polycystic kidney disease through activation of a novel ion channel. Presented at the Experimental Biology Meeting, New Orleans, 4/18/2009 - 4/22/2009
132. Bunni, M.A., Morinelli, T.A., Bell, P.D., RAYMOND, J.R.Sr., and Garnovskaya, M.B. (2010) Bradykinin B2 receptor activates extracellular signal regulated kinase in renal cells from a mouse model of polycystic kidney disease. Presented at the Experimental Biology Meeting, Anaheim CA, FASEB J April 6, 2010 24:lb703, 4/24/2010 - 4/28/2010
133. Liu, M., Idkowiak-Baldys, J., Roddy, P., RAYMOND, J.R.Sr., and Hannun, Y.A.(2011) Sustained treatment of PMA affects trafficking and signaling of EGFR. Presented at the Experimental Biology Meeting, Washington DC.FASEB J March 17, 2011 25:549.7, 4/9/2011 - 4/13/2011
134. Garnovskaya, M.N., Bunni, M.A., Bell, P.D., RAYMOND, J.R.Sr, and Coaxum, S.D. (2011) Different signaling mechanisms are involved in vasopressin-induced proliferation of orpk cilia(+)and orpk cilia(-)renal cells derived from a mouse model of polycystic kidney disease. Presented at the Experimental Biology Meeting, Washington, DC, FASEB J March 17, 2011 25:lb503, 4/9/2011 - 4/13/2011
135. Coaxum, S.D., Blanton, M.G., Bunni, M.A., Akter, T., Bell, P.D., RAYMOND, J.R.Sr. and Garnovskaya, M.N. (2011) , Epidermal growth factor-induced proliferation of renal cells from a mouse model of polycystic kidney disease involves multiple signaling pathways. Presented at the Experimental Biology Meeting, Washington DC. FASEB J March 17, 2011 25:lb505, 4/9/2011 - 4/13/2011
136. Velez, J.C.Q., Janech, M.G., Arthur J.M.and RAYMOND J.R.Sr. (2011), Cultured Human Glomerular Endothelial Cells Display ACE-Mediated Angiotensin-II-Generating Capacity and Limited Angiotensin-II-Degrading Activity. , Presented at the American Society of Nephrology Renal Week, Denver, CO, 11/16/2011 - 11/21/2011
 
International
1. Regan, J.W., RAYMOND, J.R., Li,J. et al. (1986)., Covalent labeling of alpha2-adrenergic receptors with the photoaffinity ligand [3H]-SKF102229. , Proceedings of the Congress on Biosynthesis and Regulation of Membrane-Bound Receptors. Cap d'Gade, France., 9/1986
2. Caron, M.G., Fargin, A., RAYMOND, J.R., et al. (1989) Structure and function of G protein coupled receptors. Presented at the Intemational Symposium on Serotonin: from Cell Biology to Pharmacology and Therapeutics, Florence, Italy, 3/1989
3. Nebigil, C.G, Garnovskaya, M.N., Casañas, S.J., Parker, E., RAYMOND, J.R. (1994) Agonist-induced phosphorylation and desensitization of 5-HT1A receptors expressed in baculovirus-infected insect cells. Presented at the International Congress of Pharmacology meeting, Montreal, Canada, 7/1994
4. RAYMOND, J.R., Garnovskaya, M.N. (1996) Regulation of NHE-1 activity via Gi proteins. Presented at the First Annual Meeting of Microphysiometer and FLIPR Users Group, Paris, France, 4/1997
5. Garnovskaya, M.N., Mukhin, Y., RAYMOND, J.R. (1997) , Shrinkage induced activation of Na+/H+ exchange: in search of signaling intermediates involved in regulatory volume increases in fibroblasts., Presented at the Annual Meeting of the International Union of Physical Scientists, St. Petersburg, Russia, 7/1997
6. Mukhin Y.V., Bell J., Collinsworth G.P., RAYMOND J.R., Ploth, D.W., Garnovskaya M.N. (1999) Bradykinin B2 receptor activation induces multiple cellular responses in M-1 cortical collecting duct cells. Presented at the International Society of Nephrology Meeting, Buenos Aires, Argentina, Kidney Int., 5/1999
7. Foster, S. Fitzgibbon, W. Hazen-Martin, D. Gore, E. Grotendorst, G. Trojanowska, M., RAYMOND, J.R., Greene, E.L.(2000) Angiotensin II antagonism reduces CTGF immunostaining in the UUO model of chronic nephropathy. Presented at 33rd annual meeting of the American Society of Nephrology, Toronto, Canada, JASN 11:618A (A3260), 10/10/2000 - 10/16/2000
8. Gooz, M., RAYMOND, J.R, Garnovskaya, M.N.(2003) , Cross talk between serotonin(5HT2A)and epidermal growth factor receptors (EGFR) involves heparin-binding EGF-like growth factor(HB-EGF)and activation of metalloproteinase-like enzyme(s), in rat mesangial cells. Presented at the World Congress of Nephrology, Berlin, Germany., 6/2003
9. Garnovskaya, M.N., Mukhin, Y.V., Gooz, M., RAYMOND, J.R. (2003) Matrix metalloproteinases are involved in bradykinin B2 receptor-induced epidermal growth factor receptor transactivation in kidney cells. Presented at the HUPO 2nd Annual&IUBMB XIX Joint World Congress, Montreal, Canada; Mol & Cell Proteomics 2, #9, p.910 (87.10), 10/2003
10. Göoz, M., RAYMOND, J.R, Garnovskaya, M.N.(2004) Cross-talk between Gq-coupled 5-HT2A and EGF receptor involves HB-EGF, ADAM17 and integrin activation in human mesangial cells. 12th International Conference on Second Messengers and Phosphoproteins, Montreal, Canada, 8/3/2004 - 8/7/2004
11. Turner, J.H., RAYMOND, J.R.(2004) G protein regulation of NHE-1 through Jak2 and calmodulin. 12th International Conference on Second Messengers and Phosphoproteins, Montreal, Canada, 8/3/2004 - 8/7/2004
12. Garnovskaya, M.N, , Mukhin, Y.V., Gooz, M., RAYMOND, J.R.(2004) , Matrix metalloproteinases 8 and 13 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells. , Presented at 12th International Conference on Second Messengers and Phosphoproteins, Montreal, Canada; Book of Abstracts 2004, p.128 (THP037), 8/2004
13. Göoz, M., Göoz, P., RAYMOND, J.R.(2005) Serotonin-induced ERK phosphorylation involves ADAM-17(TACE) activation in mesangial cells. 30th FEBS Congress- 9th IUBMB Conference, Budapest, Hungary, 7/2/2005 - 7/7/2005
14. Baldys, A., Göoz, M., Raymond, J.R. Jr., RAYMOND, J.R.(2007), Role of c-Cbl in trafficking and signaling of epidermal growth factor receptor (EGFR) induced by various EGFR ligands. , Presented at the 58th Mosbacher Kolloqium on Protein and Lipid Sorting in Health and Disease. Mosbach/Baden Germany, 3/29/2007 - 3/31/2007
15. Idkowiak-Baldys, J., Baldys, A., RAYMOND, J.R., Hannun, Y.A.(2007), Agonist-induced G protein-coupled receptors (GPCRs) trafficking and signaling is regulated by PKC-dependent sequestration of recycling components. , Presented at 58th Mosbacher Kolloqium on Protein and Lipid Sorting in Health and Disease. Mosbach/Baden Germany, 3/29/2007 - 3/31/2007
16. Visconti, R., LaRue, A., Gooz, RAYMOND, J.R., Gooz, M.(2008) Bone marrow cells develop into podocyte in unilateral ureteral obstruction model of kidney fibrosis. Presented at the International Podocyte Meeting, Toronto, 6/4/2008 - 6/6/2008
17. Coaxum, S.D., Garnovskaya, M.N., Gooz, M., Baldys, A., RAYMOND, J.R.(2008) Epidermal growth factor activates Na+/H+ exchange in podocytes through a mechanism that involves janus kinase and calmodulin. Presented at the International Podocyte Meeting, Toronto, 6/4/2008 - 6/6/2008
18. Gooz, M., Baldys, A., Morinelli, T.A, Gooz, P, RAYMOND, J.R.(2008) Bradykinin induces permeability changes possibly through matrix metalloenzyme activation and EGFR crosstalk in glomerular podocytes. Presented at the International Podocyte Meeting, Toronto, 6/4/2008 - 6/6/2008
 
COMMITTEE SERVICE:
Medical College
1996 - 2010 Medical University of South Carolina, Nephrology Fellowship Training Committee
1996 - 1997 MUSC Search Committee for Chairman of Physiology
1997 - 1998 MUSC University Planning Committee, Working Group for Research Issues
1997 - 1998 MUSC Search Committee for University, Chief Information Officer
1997 - 2003 MUSC Medical Student Training Program, Steering Committee
1997 - 1998 MUSC, Cost Accounting Standards Working Group on Indirect Costs
1997 - 1999 MUSC University Research Committee
1998 - 1999 MUSC Provost's Office Review Committee on the Dean of College of Dental Medicine
1998 - Present MUSC Member, Oversight Committee, Monoclonal Antibody Facility
1998 - Present MUSC Member, Oversight Committee, Flow Cytometry Facility
1999 - 2002 MUSC University Research Council
1999 - 2002 MUSC Interim Funding Committee
1999 - 2006 MUSC College of Health Professions Member, Diversity Advisory Board
1999 - 2000 MUSC Department of Medicine, Chairman, Committee to Draft Strategic Research Plan, 2001-2006
1999 - 2002 MUSC Department of Biochemistry Member, Faculty Search Committee
2000 MUSC College of Medicine, Member, Search Committee for theChair, Department of Pharmacology
2000 - 2010 MUSC Hollings Cancer Center, Member, Scientific Advisory Committee
2000 - 2001 MUSC, Member, Search Committee for the Dean, College of Medicine
2000 MUSC College of Medicine, Member, Search Committee for the Chair, Department of Microbiology and Immunology
2001 MUSC Department of Medicine, Chairman, Search Committee for the Director, Division of Cardiology
2001 MUSC College of Graduate Studies Member, Strategic Planning Committee
2001 - 2010 MUSC, Member, Steering Committee, Children's Research Institute
2001 - 2010 MUSC, Chair, Executive Research Council
2001 - 2010 MUSC, Chair, Executive Research Council
2001 - 2003 MUSC, Member, CIO Search Committee
2001 - 2010 MUSC College of Dental Medicine, Member, Steering Committee for Training grant titled "Comprehensive Training in Oral and Craniofacial Research"
2001 - Present MUSC Department of Biochemistry, Member, Oversight Committee for PPG
2001 - 2003 MUSC, Member, Information Management Council
2001 - 2003 MUSC, Member, Clinical Information Management Committee
2002 - 2010 MUSC, Member, Steering Committee, James B. Edwards College of Dental Medicine Dental School Planning and Construction project
2002 - 2010 MUSC, Member, Academic Compliance Assurance Council
2002 - 2010 MUSC, Member, University Medical Associates, Board of Directors
2002 - 2010 MUSC, Member, Internal Advisory Committee for NIH PPG titled "Molecular Mechanisms of Cardiac Hypertrophy"
 
Hospital
1996 - 2004 Veterans Affairs Medical Center, Research and Development Committee, Charleston, S.C.
1998 - Present Department of Veterans Affairs Research Space Committee
1999 - 2000 Department of Veterans Affairs, Laboratory Panic Values Committee
1999 - 2010 Dept. of Veterans Affairs and MUSC, Academic Partnership Council
2000 Ralph H. Johnson VA Medical Center Chairman, Search Committee for Chief of Staff
2000 - 2002 Ralph H. Johnson VA Medical Center, Member, Foreign Travel Subcommittee of the Education Committee
2000 - 2005 Ralph H. Johnson VA Medical Center, Chairman, Advisory Committee for the Charleston Heart Failure Research Enhancement Award Program
2001 Ralph H. Johnson VA Medical Center Member, Search Committee for the Chief, Specialty Services
2001 - 2008 Ralph H. Johnson VA Medical Center, Member, Resource Allocation Board
 
EXTRAMURAL TEACHING (e.g. at Marquette, UWM, etc.):
Community/Lay Public
1996 - 2010 University of South Carolina College of Medicine
1996 - 2001 The South Carolina Bioengineering Alliance
1996 - 2001 Charleston School of Law
1996 - 2010 Governor's School for Science and Mathematics
1996 - 2010 College of Charleston
1996 - 2010 Clemson-MUSC Bioengneering Program
 
Medical Student Education
1996 - 2010 MUSC, Teaching: College of Pharmacy, College of Health Professions, College of Dental Medicine
5/1997 - 8/1997 MUSC, Supervised Medical Students
5/1998 - 2004 MSTP, Superv: Ronald Feldman, Justin Turner
1998 - 2007 MUSC, Pharmacology Departmental Research Conferences
1998 - 2007 MUSC, Medicine Chair rounds at VAMC several times per month
1998 - 2007 MUSC, Endocrinology and Medical Genetics Seminars
1998 - 2007 MUSC, Medical Grand Rounds
1998 - 2007 MUSC, Miscellaneous divisional research conferences, clinical conferences and journal clubs
1998 - 2007 MUSC, Nephrology Ward Lectures-every other month
1998 - 2007 MUSC, Wednesday VA Nephrology Clinic- every week for 7 years
1998 - 2007 MUSC, Digestive Diseases Center Grand Rounds
1998 - 2007 MUSC, Biochemistry Seminars
1998 - 2007 MUSC, Molecular And Cellular Biology Program Seminars
1998 - 1999 Wake Forest University, Suprv. Pregraduate Scholar Preston Wendell
5/1999 - 6/2001 MUSC, Suprv: Anthony Joseph
 
Resident and Fellow Education
1996 - 2000 MUSC, Suprv. Pre-Doctoral Fellows:Mark Reploeg,DeKisha Pendergrass, Oddette Houghton, Steven Pinckney
 
Continuing Medical Education
1996 - 2010 South Carolina College of Pharmacy
1996 - 2005 MUSC, Fluid and Electrolyte and/or Acid Base Lecture(s)
1997 - 2002 MUSC, One lecture per term in the Research Instrumentation Graduate Course (Department of Cell Biology)
1997 - 1999 MUSC, 1997-1999 Two lectures per term in the Advanced Signal Transduction (Department of Pharmacology)
1998 - 2006 MUSC, Chairman’s teaching rounds. Round with long-call team at VA on Mondays for didactic teaching
 
Graduate Student Education
5/1998 - 6/2001 MUSC, Suprv Pharmacology Grad Student Tobiah Pettus
 
Postdoctoral Fellow Education
1991 - 2010 MUSC, Suprv Nephrology fellows:Frank J. Albers, Bryan N. Becker,John M. Arthur,Jasjit Grewal,Jack Andy,David Lefler,S. Steven Foster,Khurram Nazeer,Henry Ayiku,Sanju Varghese,Sonya Coaxum,Jeffrey Smith
1991 - 2010 MUSC, Suprv.Biochemistry Fellows:Maria N. Garnovskaya,Aleksander Baldys
1991 - 2010 MUSC, Suprv.Biophysics Fellow:Yurii Mukhin
1991 - 2010 MUSC, Suprv.Pharmacology Fellows:Kurt Chuprun,Canan Nebigil,Monika Gööz
 
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Faculty
Dr. Frank Park, MCW, 2010 - Present Mentorship Committee
Dr. Kevin Regner, MCW, 2010 - Present Mentorship Committee
 
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
PhD Committees
Margaret Eason , Duke University Medical Center, 1992 - 1994
Russell Nash, Duke University Medical Center, 1992 - 1995
Padla M.C. Lembo, McGill University, 1996 - 1997
Kenda L. Jameson Evans , University of Texas, San Antonio, 1997 - 1999
Ben Pender , MUSC, 1997 - 1999
John Yordy, MUSC, 1998 - 2005
Scott Commins , MUSC, 1998 - 2000
John Cleator, MUSC, 1998 - 2000
Lauren Ball, MUSC, 1999 - 2003
Steven Jones , MUSC, 1999 - 2006
Jeannie Chapman, Structural Biology Program of the Ernest Hollings Cancer Center, 1999 - 2005
Justin Turner , MUSC, 2000 - 2004 Committee Chair
Vijay Rao, MUSC, 2000 - 2003
Kevin Becker , MUSC, 2001 - 2003
Committees
Scott Commins , MUSC, 1997 - 1998 Masters Degree
MS Committees
Tobiah Pettus, MUSC, 1998 - 2000
 
Faculty
Bryan N. Becker, M.D.; Professor of Medicine and Associate Dean, College of Medicine at UIC. Dr. Becker is former Director for the Division of Nephrology at the University of Wisconsin., Mentor
Juan Carlos Q. Velez, M.D.; Associate Professor of Medicine at MUSC., Mentor
Monika Gooz, M.D., Ph.D.: Associate Professor of Medicine at MUSC., Mentor
Maria Garnovskaya, Ph.D.; Associate Professor of Medicine at MUSC., Mentor
Michael Janech, Ph.D.; Associate Professor of Medicine at MUSC., Mentor
Eddie L. Greene, M.D.; Associate Professor of Medicine and Director of the Office of Diversity, Mayo Clinic Rochester., Mentor
John M. Arthur, MD, PhD; DCI Professor of Medicine and Director of the South Carolina Center of Excellence in Renal Biomarkers at MUSC., Mentor
Sonya D. Coaxum, Ph.D.; Assistant Professor of Medicine at MUSC., Mentor
Canan Nebigil Desaubry, Ph.D.; Director of Research, CRNS - University of Strasbourg, France, Mentor
Hirendra Nath Banerjee, MBBS, PhD.; Associate Professor of Biology, Elizabeth City State University., Mentor
Odette Houghton, M.D.; Assistant Professor of Ophthalmology, UNC-Chapel Hill., Mentor
 
PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Student
2003 - 2010 MUSC Provost and Deans' Scholarship Program
Faculty
2002 - 2010 MUSC Women Scholars Initiative
2005 - 2010 MUSC Trustee Leadership Academy
 
Research Programs
1998 - 2010 NIH T32 Training Grant and VA REAP Award
2002 - 2010 SC Centers of Economic Excellence Program
2005 - 2010 Research Project Grant Retreats
 
 
 
COMMUNITY SERVICE ACTIVITIES:
Dr. Raymond is a 6-gallon blood donor


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. RAYMOND, J.R. (1984) Nephrotoxicities of antineoplastic and immunosuppressive agents. Current Problems in Cancer 8:2-32.
2. Regan, J.W., RAYMOND, J.R., Lefkowitz, R.J., DeMarinis, R.M. (1986) Photoaffinity labeling of human platelet and rabbit kidney 2-adrenergic receptors with [3H]-SKF 102229. Biochem. Biophys. Res. Comm. 137:606-613.
3. RAYMOND, J.R. (1988) Amphotericin B nephrotoxicity. Am. Family Physician 38: 199-203.
4. RAYMOND, J.R., Raymond, P.A. (1988) Post-lumbar puncture headache. West. J. Med. 148: 551- 554.
5. RAYMOND, J.R., Yarger, W.E. (1988) Abnormal urine color; differential diagnosis. South. Med. J. 81:837- 841.
6. RAYMOND, J.R., van den Berg, E.K. Jr., Knapp, M. (1988) Nontraumatic prehospital sudden death in young adults. Arch. Intern. Med. 148:303-308.
7. Fargin, A., RAYMOND, J.R., Lohse, M., Kobilka, B.K., Caron, M.G., Lefkowitz, R.J. (1988) A genomic clone which resembles a ß-adrenergic receptor encodes the 5-HTlA receptor. Nature 335:358-360.
8. Schwab, S.J., RAYMOND, J.R., Saeed, M., Dennis, P., Bollinger, R. (1989) Prevention of hemodialysis fistula thrombosis; early detection and elective treatment of venous stenoses. Kidney Int. 36:707-711.
9. RAYMOND, J.R., Fargin, A., Lohse, M.J., Regan, J.W., Senogles, S., Lefkowitz, R.J., Caron, M.G. (1989) Identification of the ligand binding subunit of the 5-HT1A receptor with a radioiodinated probe. Mol. Pharmacol. 36:15-21.
10. Fargin, A., RAYMOND, J.R., Regan, J.W., Cotecchia, S., Lefkowitz, R.J., Caron, M.G. (1989) Effector coupling mechanisms of the cloned 5-HT1A receptor. J. Biol. Chem. 264:14848-14852.
11. RAYMOND, J.R., Fargin, A., Middleton, J.P., Graff, J.M., Haupt, D.M., Caron, M.G., Lefkowitz, R.J., Dennis, V.W. (1989) The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate transport via protein kinase C. J. Biol. Chem. 264:21943-21950.
12. Thevaniau, M., RAYMOND, J.R., Rougon, G.N. (1989) Antipeptide antibodies to the beta2-adrenergic receptor confirm the extracellular orientation of the amino terminus and the putative first extracellular loop. J. Membr. Biol. 111:141-153.
13. RAYMOND, J.R., Hnatowich, M.R., Lefkowitz, R.J., Caron, M.G. (1990) Adrenergic receptors: proto-types for the study of structure and function of G-protein-coupled receptors. Hypertension 15:119-131.
14. RAYMOND, J.R., Middleton, J.P., Dennis, V.W. (1990) HeLa cells express cAMP-inhibitable sodium-dependent phosphate uptake. Am. J. Physiol 258: (Renal Fluid Electrolyte Physiol. 27) F433-F437.
15. Middleton, J.P., Albers, F.J., Dennis, V.W., RAYMOND, J.R. (1990) Thapsigargin provides evidence for Ca2+-mediated increases in sodium-dependent phosphate uptake in HeLa cells. Am. J. Physiol 259: (Renal Fluid Electrolyte Physiol. 28) F727-F731.
16. Middleton, J.P., RAYMOND, J.R., Whorton, A.R., Dennis, V.W. (1990) Recombinant 5-HTlA receptors stimulate Na+/K+-ATPase by a Ca2+-dependent pathway in HeLa cells. J. Clin. Invest. 86:1799-1805.
17. RAYMOND, J.R., Albers, F.J., Middleton, J.P., Caron, M.G., Lefkowitz, R.J., Dennis,V.W. (1991) Serotonin 5-HTlA and histamine Hl receptors expressed in HeLa cells stimulate phosphatidylinositol hydrolysis and phosphate uptake through distinct G protein pools. J. Biol. Chem. 266:372-379.
18. Bates, M.D., Caron, M.G., RAYMOND, J.R. (1991) Desensitization of DAl dopamine receptors coupled to adenylate cyclase in opossum kidney (OK) cells. Am. J. Physiol 260: (Renal Fluid Electrolyte Physiol. 29) F937-F945.
19. RAYMOND, J.R. (1991) Protein kinase C induces phosphorylation and desensitization of the human 5-HTlA receptor. J. Biol. Chem. 266:14747-14753.
20. El Mestikawy, S., Fargin, A., RAYMOND, J.R., Gozlan, H., Hnatowich, M. (1991) The 5-HTlA receptor: an overview of recent advances. Neurochemical Res. 16:1-10.
21. Jose, P.A., RAYMOND, J.R., Bates, M.D., Aperia, A., Felder, R.A., Carey, R.M. (1992) The renal dopamine receptors. J. Am. Soc. Nephrol. 2:1265-1278.
22. Liggett, S.B., Ostrowski, J., Chesnut, L.C., Kurose, H., RAYMOND, J.R., Caron, M.G., Lefkowitz, R.J. (1992) Sites in the third intracellular loop of the alpha2-adrenergic receptor confer short-term term agonist-promoted desensitization: evidence for a receptor kinase mediated mechanism. J. Biol. Chem. 267:4740-4746.
23. Boddeke, H.W.G.M., Fargin, A., RAYMOND, J.R., Schoeffter, P., Hoyer, D. (1992) Agonist/antagonist interactions with cloned human 5-HTlA receptors: variations in intrinsic activity in HeLa cells. Naunyn-Schmied. Arch. Pharmacol. 345:257-263.
24. Ho, B.Y., Karschin, A., RAYMOND, J.R., Branchek, T, Lester, H.A., Davidson, N. (1992) Expression in animal cells of the 5-HT1A receptor by a vaccinia virus vector system. FEBS Lett. 301:303-306.
25. Mangel, A.W., Basavappa, S., Gabriel, S., RAYMOND, J.R., Stutts, M.J., Fitz, J.G. (1992) cAMP-regulated chloride currents in CHO cells. Biochem. Biophys. Res. Commun. 186:251-255.
26. Eason, M., Kurose, H., Holt, B., RAYMOND, J.R., Liggett, S.B. (1992) Simultaneous coupling of alpha2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 267:15795-15801.
27. RAYMOND, J.R., Albers, F.J., Middleton, J.P. (1992) Functional expression of human 5-HTlA receptors and differential coupling in CHO cells. Naunyn-Schmied. Arch. Pharmacol. 346:127-137.
28. Becker, B.B., Gettys, T.W., Albers, F.J., Middleton, J.P., Lee, S.-L., Fanburg, B., RAYMOND, J.R. (1992) 8-OH-DPAT-responsive 5-HT4-like receptor expressed in bovine pulmonary artery smooth muscle cells. Mol. Pharmacol. 42:817-825.
29. RAYMOND, J.R., Kim, J.L., Beach, R.E., and Tisher, C.C. (1993) Immunohistochemical mapping of the cellular & subcellular distribution of 5-HT1A receptors in rat and human kidney. Am. J. Physiol. 264: (Renal Fluid Electrolyte Physiol. 33) F9-F19.
30. Mangell, A., RAYMOND, J.R., Fitz, J.G. (1993) Regulation of high-conductance anion channels by G proteins and 5-HTlA receptors in CHO cells. Am. J. Physiol. 264: (Renal Fluid Electrolyte Physiol. 33) F490-F495.
31. Arthur, J.M., Casañas, S.J., RAYMOND, J.R. (1993) Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors. Biochem. Pharmacol. 45: 2337-2341.
32. Bates, M.D., Olsen, C.L., Becker, B.N., Albers, F.J., Middleton, J.P., Mulheron, J.G., Jin, C., Conti, M., RAYMOND, J.R. (1993) Elevation of cAMP is required for down-regulation, but not agonist-induced desensitization of dopamine D1 receptors. Studies in opossum kidney cells that stably express a rat phosphodiesterase 3 cDNA J. Biol. Chem. 269:14757-14763.
33. Bian, X., Seidler, F., Olsen, C.L, RAYMOND, J.R., Slotkin, T. (1993) Effects of fetal dexamethasone exposure on postnatal control of cardiac adenylate cyclase: -adrenergic receptor coupling to Gs regulatory protein. Teratology 48:169-177.
34. RAYMOND, J.R., Olsen, C.L., Gettys, T.W. (1993) Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein -subunits and lack of coupling to Gs-alpha. Biochemistry 32:11064-11073.
35. Gettys, T.W., Fields, T.A., RAYMOND, J.R. (1994) Selective activation of inhibitory G protein alpha-subunits by partial agonists of the human 5-HTlA receptor. Biochemistry 33:4283-4290.
36. Mulheron, J.G., Casañas, S.J., Arthur, J.M., Garnovskaya, M.N., Gettys, T.W., RAYMOND, J.R. (1994) Human 5-HTlA receptors expressed in insect cells activate endogenous Go-like G proteins. J. Biol. Chem. 269:12954-12962.
37. RAYMOND, J.R., Arthur, J.M., Olsen, C.L., Gettys, T.W, Mortensen, R.M. (1994) 2A Adrenergic receptors inhibit cAMP accumulation in embryonic stem cells which lack Gi-alpha. J. Biol. Chem. 269:13073-13075.
38. Spurney, R.F., Middleton, J.P, RAYMOND, J.R., Coffman, T.M. (1994) Modulation of thromboxane receptor activation in rat glomerular mesangial cells. Am. J. Physiol. 267: (Renal Fluid Electrolyte Physiol. 36) F467-F478.
39. Quarles, L.D., Middleton, J.P., Zhang, J., Arthur, J.M., RAYMOND, J.R. (1994) Aluminum-induced DNA synthesis in MC3T3-E1 osteoblasts: mediation by G-protein and protein kinase C dependent pathways. J. Cell. Biochem. 56:106-117.
40. Gettys, T.W., Sheriff-Carter, K., Moomaw, J., Taylor, I.L., RAYMOND, J.R. (1994) Characterization and use of crude alpha-subunit preparations for quantitative immunoblotting of G proteins. Anal. Biochem. 220:82-91.
41. RAYMOND, J.R., Olsen, C.L. (1994) PKA induces phosphorylation of the human 5-HT1A receptor and augments its desensitization by protein kinase C in CHO-K1 cells. Biochemistry 33:11264-11269.
42. RAYMOND, J.R., Arthur, J.M., Mannon, R. (1994) Practical management of hypertensive urgencies and emergencies. N. Carolina Med. J. 55:295-303.
43. RAYMOND, J.R., Arthur, J.M., Kovalik, E. (1994) Strategies for preventing diabetic nephropathy. N. Carolina Med. J. 55:362-369.
44. RAYMOND, J.R. (1994) Hereditary and acquired defects in signaling through the hormone-receptor-G protein complex. Am. J. Physiol. 266: (Renal Fluid Electrolyte Physiol. 35) F163-F174.
45. RAYMOND, J.R. (1995) Multiple mechanisms of receptor/G protein signaling specificity. Am. J. Physiol. 268: (Renal Fluid Electrolyte Physiol. 37) F141-F158.
46. Nebigil, C.G., Garnovskaya, M.N., Spurney. R.F., RAYMOND, J.R. (1995) Identification of a rat glomerular mesangial cell mitogenic 5-HT2A receptor. Am. J. Physiol. 268: (Renal Fluid Electrolyte Physiol. 37) F122-F127.
47. Garnovskaya, M.N., Nebigil C.G., Arthur, J.M., Spurney, R.F., RAYMOND, J.R. (1995) 5-HT2A receptors expressed in rat mesangial cells inhibit cAMP accumulation. Mol. Pharmacol. 48:230-237.
48. Nebigil, C.G., Garnovskaya, M.N., Casañas, S.J., Mulheron, J.G., Parker, E.M., Gettys, T.W., RAYMOND, J.R. (1995) Agonist-induced phosphorylation and desensitization of 5-HT1A receptor expressed in Sf9 insect cells. Biochemistry 34:11954-11962.
49. van Biesen, T., Hawes, B.E., RAYMOND, J.R., Luttrell, L.M., Koch, W.J., Lefkowitz, R.J. (1996) Go-protein alpha-subunits mediate Ras-independent MAP kinase activation. J. Biol. Chem. 271:1266-1269.
50. Wang, Y., Sostman, A., Roman, R., Vigna, S., RAYMOND, J.R., Fitz, J.G. (1996) Metabolic stress activates K+ channels through a Ca2+ and protein kinase C-alpha-dependent mechanism. J. Biol. Chem. 271:18107-18113.
51. Kovalik, E.C., RAYMOND, J.R., Berkoben, M.S., Butterly, D.W., Montello, B.J., Conlon, P.J. (1996) A cluster of epidural abscesses in chronic hemodialysis patients. J. Am. Soc. Nephrol. 7:2264-2267.
52. Kirchgessner, A.L., Liu, M.-T., RAYMOND, J.R., Gershon, M.D. (1996) Identification of cells that epsilon-xi-pi-rho-epsilon-sigma-sigma 5-HTlA receptors in the nervous systems of the bowel and pancreas. J. Comp. Neurol. 364:439-455.
53. Garnovskaya, M.N., van Biesen, T., Hawes, B.E., Canañas Ramos, S.J., Lefkowitz, R.J., RAYMOND, J.R. (1996) Ras-dependent activation of mitogen-activated protein kinase by 5-HT1A receptor. Biochemistry 35:13716-13722.
54. Chuprun, J.K., RAYMOND, J.R., Blackshear, P.J. (1997) Heterotrimeric G protein Gi-alpha2 mediates LPA-stimulated mitogenic signalling in mouse fibroblasts. J. Biol. Chem. 272:773-780.
55. Garnovskaya, M.N., Gettys, T.W., van Biesen, T., Chuprun, J.K., Prpic, V., RAYMOND, J.R. (1997) G protein-coupled 5-HTlA receptor activates Na+/H+ exchange in CHO-K1 cells through Gi-alpha2 and Gi-alpha3. J. Biol. Chem. 272: 7770-7776.
56. Wang, Y., Roman, R., Hannun, Y., RAYMOND, J.R., Fitz, J.G. (1997) Activation of protein kinase C-alpha couples cellular metabolism to membrane K+ in a human biliary cell line. J. Clin. Invest. 99:2890- 2897.
57. Arthur, J.M., Collinsworth, G.P., Quarles, L.D., Gettys, T.W., RAYMOND, J.R. (1997) Specific coupling of a cation-sensing receptor to G protein a-subunits in MDCK cells. Am. J. Physiol. 273: (Renal Fluid Electrolyte Physiol. 42) F129-F135.
58. Ullian, M.E., RAYMOND, J.R., Paul, R.V. (1997) Regulation of vascular angiotensin II receptors by EGF. Am. J. Physiol. 273: (Cell Physiol. 42) C1241-C1249.
59. Garnovskaya, M.N., Mukhin, Y., RAYMOND, J.R. (1998) Rapid activation of sodium-proton exchange and extracellular signal-regulated protein kinase in fibroblasts by G protein-coupled 5-HT1A receptor involves distinct signaling cascades. Biochem. J. 330:489-495.
60. Mannon, P.J., RAYMOND, J.R. (1998) The neuropeptide Y/peptide YY Y1 receptor is coupled to MAP kinase via PKC and Ras in CHO cells. Biochem. Biophys. Res. Comm. 246:91-94.
61. Prpic, V.J., Fitz, J.G., RAYMOND, J.R., Garnovskaya, M.N., Liddle, R.A. (1998) Inhibition of Na+/H+ exchange stimulates cholecystokinin secretion in STC-1 cells. Am. J. Physiol. 275:G689-95
62. Moiseiwitsch, J.R.D., RAYMOND, J.R., Tamir, H, Lauder, J.M. (1998) Serotonin regulates tooth germ morphogenesis and gene expression in mouse mandibular explant cultures. Arch. Oral Biol. 43:789-800.
63. Roman, R., Bodily, K.O., Wang, Y., RAYMOND, J.R., Fitz, J.G. (1998) Activation of protein kinase C-alpha couples increases in cell volume to membrane Cl- permeability in HTC hepatoma and Mz-ChA-1 cells. Hepatology. 28:1073-1080.
64. Della Rocca, G.J., Mukhin, Y.V., Garnovskaya, M.N., Daaka, Y., Clark, G., Luttrell, L.M., Lefkowitz, R.J., RAYMOND, J.R. (1999) Serotonin 5-HT1A receptor-mediated MAP kinase activation requires calcium/calmodulin-mediated receptor endocytosis. J. Biol. Chem. 274:4749-4753.
65. Pahan, K., RAYMOND, J.R., Singh, I. (1999) Inhibition of phosphatidylinositol 3-kinase induces nitric oxide synthase in LPS or cytokine stimulated C6 glial cells. J. Biol. Chem. 274:7528-7536.
66. Chen, R., Greene, E.L., Collinsworth, G., Grewal, J., Houghton, O., Wackym. P., Zang, H., Paul, R.V., RAYMOND, J.R. (1999) A method for efficient expression of cDNA constructs in primary cultures of rat renal mesangial cells. Am. J. Physiol. 276:F777-F785.
67. Grewal, J., Mukhin, Y.V., Garnovskaya, M.N., RAYMOND, J.R., Greene, E.L. (1999) Serotonin 5-HT2A receptor induces TGF-1 mRNA and protein in rat mesangial cells via ERK. Linkage between proliferative and fibrotic signals. Am. J. Physiol. 276:F922-F930.
68. Arthur, J.M., Collinsworth, G.P., Gettys, T.W., RAYMOND, J.R. (1999) Agonist-induced translocation of Gq/11alpha directly from plasma membranes in MDCK cells. Am. J. Physiol. 276:F528-F534.
69. RAYMOND, J.R., Mukhin, Y.V., Garnovskaya, M.N. (1999) The recombinant 5-HT1A receptor: G protein coupling and signalling pathways. British J. Pharmacol. 127:1751-1764.
70. Tholanikunnel, B.G., RAYMOND, J.R., Malbon, C.C. (1999) Detailed mutational sequence analysis of the destabilizing (A+U)-rich 3'-untranslated region of the beta2-adrenergic receptor mRNA across different species. Biochemistry 38:15564-15572.
71. Mukhin, Y.V., Garnovskaya, M.N., Collinsworth, G., Nagai, T., Pinckney, S., Pendergrass, D., Greene, E.L., RAYMOND, J.R. (2000) 5-HT1A receptor couples through G-beta-gamma and Src to stimulate mitogen-activated protein kinase via reactive oxygen species in fibroblasts. Biochem. J. 347:61-67.
72. Greene, E.L Houghton, O., Collinsworth, G., Garnovskaya, M.N., Nagai, T., Sajjad, T.,Bheemanathini, V., Grewal, J., Paul, R.V., RAYMOND, J.R. (2000) 5HT2A receptors stimulate mitogen-activated protein kinase via ROS in rat renal mesangial cells. Am. J. Physiol. 278: F650-F658.
73. Pahan K., Liu, X., McKinney, M.J., Wood, C., Sheikh, F.G., RAYMOND, J.R. (2000) Expression of a dominant-negative mutant of p21ras inhibits induction of nitric oxide synthase and activation of NF-B in primary astrocytes. J. Neurochem. 74:2288-2295.
74. Pahan K., Liu, X., McKinney, M.J., Wood, C., Sheikh, F.G., RAYMOND, J.R. (2000) Expression of a constitutively active form of phosphatidylinositol 3-kinase inhibits the induction of nitric oxide synthase in human astrocytes. FEBS Lett. 472:203-207.
75. Chen, R. Garnovskaya, M., Thielen, T., Iijima, Y., Huang, C., RAYMOND, J.R., Ullian, M.E., and Paul, R.V. (2000) Increase in nuclear localization of an angiotensin II type I receptor-GFP fusion protein after angiotensin II exposure. Am. J. Physiol. Renal Physiol. 279:F44-F448, 2000.
76. Mukhin, Y.V., Garnovskaya, M.N., Collinsworth, G., Bell, J.L., Tholanikunnel, B.G., Pettus, T., Jaffa, A.A., Fitzgibbon, W., Ploth, D.W., RAYMOND, J.R., Garnovskaya, M.N. (2001) Bradykinin B2 receptors activate Na+/H+ exchange in mIMCD-3 cells via Ca2+/calmodulin. J. Biol. Chem. 276: 17339-17346.
77. Grewal, J.S., Luttrell, L.M., RAYMOND, J.R. (2001). G protein-coupled receptors desensitize and down- regulate EGF receptors in renal mesangial cells. J. Biol. Chem. 276:27335-27344.
78. RAYMOND, J.R., Mukhin, Y.V., Gelasco, A., Turner, J., Collinsworth, G., Gettys, T.W., Grewal, J.S., Garnovskaya, M.N. (2002) Multiplicity of Mechanisms of Serotonin Receptor Signal Transduction. Pharmacology and Therapeutics 92:179-212.
79. Lefler, D., Mukhin, Y.V., Pettus, T., Leeb-Lundberg, L.M.F., Garnovskaya, M.N, RAYMOND, J.R. (2003) Jak2 and Ca2+/calmodulin are key intermediates for bradykinin B2 receptor-mediated activation of Na+/H+ exchange in KNRK and CHO Cells. Assay Drug Devel. Technol. 1:281-289.
80. Garnovskaya, M.N., Mukhin, Y.V., Vlasova, T., RAYMOND, J.R. (2003) Hypertonicity activates Na+/H+ exchange through Janus kinase 2 and Ca2+/calmodulin. J. Biol. Chem. 278:16908-16915.
81. Garnovskaya, M.N., Mukhin, Y.V., Turner, J., Vlasova, T., Ullian, M.E., RAYMOND, J.R. (2003) Mitogen-induced activation of Na+/H+ exchange in vascular smooth muscle cells involves Janus kinase 2 and Ca2+/calmodulin. Biochemistry 42:7178-7187.
82. Budisavljevic, M.N., Hodge, L., Barber, K., Fulmer, J.R., Durazo-Arvizu, R.A., Self, S.E., Kuhlmann, M., RAYMOND, J.R., Greene, E.L. (2003) Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am. J. Physiol. Renal Physiol. 285:F1138-1148.83.
83. Banerjee, H., Hawkins, Z,. Johnson, T., Eley, S., Alikhan, A., McDaniel, M., Singh, I., RAYMOND, J. (2003) Identification of a mouse orthologue of the CED-6 gene of Caenorhabditis elegans. Plasmid 49: 30-33.
84. Mukhin, Y.V., Garnovskaya, M.N., Ullian, M.E., RAYMOND, J.R. (2004) ERK is regulated by sodium- proton exchanger in rat aortic vascular smooth muscle cells. J. Biol. Chem. 279:1845-1852.
85. Turner, J.H., Gelasco, A.K., RAYMOND, J.R. (2004) Calmodulin interacts with the third intracellular loop of the serotonin 5-HT1A receptor: Possible role in receptor phosphorylation by protein kinase C. J. Biol. Chem. 279:17027-17037.
86. Garnovskaya, M.N., Mukhin, Y.V., Grewal, J.S., Tholanikunnel, B.G., Ullian, M.E., RAYMOND, J.R. (2004) MEK is an intermediate for rapid phosphorylation of serine 795 of the retinoblastoma gene product in vascular smooth muscle cells. J. Biol. Chem. 279:24899-24905.
87. Subramaniam, K., Chen, K., Joseph, K., RAYMOND, J.R., and Tholanikunnel, B.G. (2004) The 3'-untranslated region of the beta2-adrenergic receptor mRNA regulates receptor synthesis. J. Biol. Chem. 279:27108-27115.
88. Lefler, D.M., Pafford, R.G., Black, N., RAYMOND, J.R., and Arthur, J.M. (2004) Identification of proteins in slow continuous ultrafiltrate by reverse phase chromatography and proteomics. J. Proteome Res. 3:1254-1260.
89. Jamison, R.L., Hartigan, P., Gaziano, J.M., Fortmann, S.P., Goldfarb, D.S., Haroldson, J.A., Kaufman, J., Lavori, P., McCully, K.S., Robinson, K., and the HOST investigators* (2004) Design and statistical issues in the Homocysteinemia in kidney and end stage renal disease (HOST) study. Clinical Trials 1:451-460. *Dr. Raymond is a HOST investigator.
90. Dave, S., Honney, S., RAYMOND, J.R., and Flume, P.A. (2005) An unusual case of cystic fibrosis presenting in adulthood with hypokalemic metabolic alkalosis. Am. J. Kidney Dis. 45:e41-e44.
91. Kandasamy, K., Joseph, K., Subramaniam, K., Joseph, K., RAYMOND, J.R., and Tholanikunnel, B.G. (2005) Translational control of the beta2-adrenergic receptor mRNA by T-cell-restricted intracellular antigen-related protein (TIAR). J. Biol. Chem. 280:1931-1943.
92. Turner, J.H., and RAYMOND, J.R. (2005) Interaction of calmodulin with the serotonin 5- hydroxytryptamine2A receptor: A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C. J. Biol. Chem. 280: 30741-30750.
93. Gelasco, A.K., and RAYMOND, J.R., (2006) Indoxyl sulfate induces complex redox alterations in mesangial cells. Am. J. Physiol. Renal Physiol. 290:F1551-F1558.
94. Mukhin, Y.V., Gooz, M., RAYMOND, J.R., and Garnovskaya, M.N. (2006) Collagenases 2 and 3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells. J. Pharmacol. Expt. Ther. 318:1033-1040.
95. Gooz, M., Gooz, P., Luttrell, L.M., and RAYMOND, J.R. (2006) Serotonin induces ERK phosphorylation and proliferation through ADAM-17 (TACE) activation and HB-EGF shedding in mesangial cells. J. Biol. Chem. 281:21004-21012.
96. Turner, J.H., Garnovskaya, M.N., Coaxum, S.D., Vlasova, T.M., Yakutovich, M.D., Lefler, D.M., and RAYMOND, J.R. (2007) Ca2+/calmodulin and Jak2 are required for activation of sodium-proton exchange by the Gi-coupled 5-hydroxytryptamine 5-HT1A receptor. J. Pharmacol. Expt. Ther. 320:314-322.
97. Alvi, F., Idkowoak-Baldys, J., Baldys, A., RAYMOND, J.R., Hannun, Y.A. (2007) Regulation of membrane trafficking and endocytosis by Protein Kinase C; Emerging role of the pericentrion, a novel PKC-dependent subset of recycling endosomes. Cell. Mol. Life Sci. 64:263-270.
98. Janech, M.G., RAYMOND, J.R., Arthur, J.M. (2007) Proteomics in Renal Research. Am. J. Physiol. Renal. 292:F501-12
99. Morinelli, T.A., RAYMOND, J.R., Yang, Q., Lee, M.-h., Luttrell, L., and Ullian, M.E. (2007) Identification of a putative nuclear localization sequence within the angiotensin II AT1A receptor. Am. J. Physiol. Cell. 292:1398-1408.
100. Turner, J.H., Garnovskaya, M.N., RAYMOND, J.R. (2007) 5-HT1A receptor regulates JNK activity and apoptosis through the intermediary actions of monomeric G proteins. Biochim Biophys Acta - Mol Cell Res. 1773:391-399.
101. Varghese, S.A, Powell, T.B., Budisavljevic, M.N., Oates, J.C., RAYMOND, J.R., Almeida, J.S., Arthur, J.M. (2007) Urine biomarkers predict the cause of glomerular disease. J. Am. Soc. Nephrol. 18:913-922.
102. Velez, J.C.Q., Bland, A.M., Arthur, J.M., RAYMOND, J.R., Janech, M.G. (2007) Characterization of renin-angiotensin system enzyme activities in podocytes. Am. J. Physiol. Renal. 293:F398-407.
103. Jamison, R.L., Hartigan, P., Kaufman, J., Goldfarb, D.S., Warren, S.R., Guarino, P.D., Graziano, J.M., and the HOST investigators* (2007) Effect of homocysteine lowering on mortality and vascular disease in in advanced chronic kidney disease and end-stage renal disease (HOST) study. JAMA 298:1163-1170. *Dr. Raymond is a HOST investigator.
104. Kramarenko, I., Bunni, M., Morinelli, T., RAYMOND, J.R., Sr., Garnovskaya, M.N. (2009) Identification of functional bradykinin B2 receptors expressed in HEK293 cells. Biochem. Pharmacol. 77:269-276. PMCID: PMC2645039
105. Baldys, A., Göoz, M., Lee, M.-H., Raymond, J.R., Jr. , Luttrell, L.M., and RAYMOND, J.R., Sr. (2009) Essential role of c-Cbl in amphiregulin-induced trafficking and signaling of recycling epidermal growth factor receptor (EGFR). Biochemistry. 48:1462-1473. PMCID: PMC2645952.
106. Velez, J.C., Ryan, K.J., Harbeson, C.E., Woodsworth, C.L., Bland, A.M., Budisavljevic, M.N., Arthur, J.M., Fitzgibbon, W.R., RAYMOND, J.R., Janech, M.G. (2009) Angiotensin is largely converted to Angiotensin- (1-7) and Angiotensin-(2-10) by isolated rat glomeruli. Hypertension 53:790-797. PMCID: PMC2706530
107. Coaxum, S.D., Garnovskaya, M.N., Gooz, M., Baldys, A., and RAYMOND, J.R. (2009) Epidermal growth factor activates Na+/H+ exchanger in podocytes through a mechanism that involves janus kinase and calmodulin. Biochem. Biophys. Acta. 1793:1174-1181. PMID: 19341767
108. Idkowiak-Baldys, J., Baldys, A., RAYMOND, J.R., Hannun, Y.A. (2009) Sustained receptor stimulation leads to sequestration of recycling endosomes in a cPKC and phospholipase D dependent manner. J. Biol. Chem. 284(33):22322-22331.
109. Baldys, A. RAYMOND, J.R. (2009) Critical Role for ESCRT Machinery in EGFR Recycling. Biochemistry 48:9321-9323 (Rapid Communication). Chosen as featured article on the Journal's web site.
110. Brady, C.B., Gaziano, J.M., Cxypoliski, R.A., Guarino, P.D., Kaufman, J.S., Warren, S.R., Hartigan, P., Goldfarb, D.S., Jamison, R.L.* (2009) Homocysteine Lowering and Cognition in CKD: The Veterans Affairs Homocysteine Study. Am. J. Kidney Dis. 54::440-449. PMID: 19628319. *Dr. Raymond is a HOST investigator.
111. Best, C.L. Smith, D.W., RAYMOND, J.R., Sr., Greenberg, R.S., and Crouch, R.K. (2010) Preventing and Responding to complaints of sexual harassment in a medical university: A 10-year review of a successful program. Academic Medicine 85:722-727.
112. Dey, M., Baldys, A., Sumter, D.B., Gooz, P., Luttrell, L.M., RAYMOND, J.R., and Gooz, M. (2010) Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement J. Pharmacol. Expt. Ther. 334:775-783. PMID: 20566668; PMCID: PMC2939663.
113. Blue, A., Smith, T.G., RAYMOND, J.R., Greenberg, R.S., Mitcham, T.G. (2010) Embedding interprofessional education through conceptual and operational frameworks. Academic Medicine 85:1290-1295.
114. Kramarenko, I.I., Bunni, M.A., RAYMOND, J.R., and Garnovskaya, M.N. (2010) Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells. Molecular Pharmacology 78:126-134. PMID: 20385709; PMCID: PMC2912058
115. Tholanikunnel, B.G., Joseph, K., Kandasamy, K., Baldys, A., RAYMOND, J.R., Luttrell, L.M., McDermott, P.J., and Fernandes, D.J. (2010) Mechanisms in the regulation of G protein-coupled receptor trafficking to the plasma membrane. J. Biol. Chem. 285:33816-33825. PMID: 20739277; PMCID: PMC2962481
116. Bunni, M.A., Kramarenko, I.I., Walker, L.P., RAYMOND, J.R., and Garnovskaya, M.N. (2011) Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 300:C647-C656. PMID: 21148411; PMCID: PMC3063971.
117. Baldys, A., and RAYMOND, J.R. (2011) Role of c-Cbl carboxyl terminus in serotonin 5-HT2A receptor recycling and resensitization. J. Biol. Chem. 286: 24656-24665. PMID 21464131; PMCID: PMC3137041
 
Books, Chapters, and Reviews
1. RAYMOND, J.R., Hnatowich, M.R., Caron, M.G., Lefkowitz, R.J. (1990) Structure-function relationships of G protein-coupled receptors. In: ADP-Ribosylating Toxins and G Proteins: Insights into Signal Transduction (Moss, J., and Vaughan, M., Eds.). Am. Soc. Microbiol., pp 163-188.
2. Dennis, V.W., Middleton, J.P., RAYMOND, J.R., Dunham, C., Sens, D. (1990) Phosphate uptake in human proximal renal cells. In Diuretics 3: Chemistry, Pharmacology,and Clinical Applications (Puschett, J.B., and Greenberg, A., Eds.). Elsevier, New York, pp 131-155.
3. Fargin, A., RAYMOND, J.R., Caron, M.G. (1990) Biochemical characterization of the human 5-HTlA receptor, genomic clone (G21), expressed in mammalian cells. In Serotonin: from Cell Biology to Pharmacology and Therapeutics (Paoletti, R., and Vanhoutte, P.M., Eds.). Kluwer Academic Publishers, Netherlands, pp 19-24.
4. RAYMOND, J.R., El Mestikawy, S., Fargin, A. (1992) The 5-HTlA receptor: from molecular characteristics to clinical correlates. In: Molecular Biology of Receptors which Couple to G Proteins (Brann, M., Ed.). Birkhauser Boston, Cambridge, MA, pp. 113-141.
5. Liggett, S.B., RAYMOND, J.R. (1993) Pharmacology and molecular biology of adrenergic receptors. In: The Catecholamines (Bouloux, E., Ed.). W.B. Saunders, London, UK, pp. 279-305.
6. RAYMOND, J.R., Turner, J., Ayiku, H., Lefler, D., Gelasco, A., Arthur, J.M. (2005) Use of mass spectrometry to identify receptor-interacting proteins. In: G Protein-coupled Receptor Interacting Proteins. pps. 179-199. (George, S., O'Dowd, B, and Sibley, D., Eds.). Wiley Press, Indianapolis.
7. RAYMOND, J.R., Turner, J.H., Gelasco, A, Ayiku, H., Coaxum, S., Arthur, J.M., and Garnovskaya, M.N. (2006) 5-HT Receptor Signal Transduction Pathways. In: The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics. (Roth, B. Ed.), pp 143-206. The Humana Press, Inc., Totowa, NJ.
8. TURNER, J.H., Coaxum, S.D., Gelasco, A.V., and RAYMOND, J.R. (2007) Calmodulin is a 5-HT Receptor Interacting and Regulatory Protein. In: Frontiers in Neuroscience. Serotonin Receptors in Neurobiology. (Chattopadhyay, A. Ed.), (Nicolelis, M. and Simon, S. Series Eds.), Chapter 4, pp 61-80, CRC Press, Boca Raton, FLA.
9. Garnovskaya M.N,. RAYMOND J.R. (2009) Serotonin 5-HT2C Receptor Signal Transduction. In: The Pathophysiology of Central 5-HT2C Receptors. (Di Giovanni, G., and Di Matteo, E. Eds.). Humana Press/Springer, New York, USA.
 
Editorials, Letters to Editor, Other
1. Inglese, J, and RAYMOND, J.R (2003) Robert J. Lefkowitz, M.D., Mentor extraordinaire. Assay Drug Devel. Technol 1:227-232.
2. RAYMOND, J.R (2011) Institute for Health and Society provides framework, resources for community-engaged activities. Wisconsin Medical Journal 110:45-46. PMID 21473514
 
Abstracts
1. van den Berg, E.K. Jr., RAYMOND, J.R., Knapp, M. (1985) Sudden death in young adults. Chest 88: 11S.